|
Box | Folder
|
Title
|
|
Experiments by Series,
1949-2003 [subseries]:
|
|
AE series,
1975 [subseries]:
|
2 |
22 |
AE1,
4/3/1975
|
2 |
23 |
AE2,
4/4/1975
|
2 |
24 |
AE3(discarded),
4/9/1975
|
2 |
25 |
AE4,
4/10/1975
|
2 |
26 |
AE5,
4/14/1975
|
2 |
27 |
AE6,
4/17/1975
|
2 |
28 |
AE7,
4/28/1975
|
2 |
29 |
AE8,
5/7/1975
|
2 |
30 |
AE9,
5/8/1975
|
2 |
31 |
AE10,
5/19/1975
|
2 |
32 |
AE11 (discarded),
5/20/1975
|
2 |
33 |
AE12,
5/22/1975
|
|
AMP series,
1976 [subseries]:
|
2 |
34 |
AMP -- behavior,
1976
|
2 |
35 |
D-AMP-DG-1,
6/8/1976
|
2 |
36 |
D-AMP-DG-2,
6/16/1976
|
2 |
37 |
D-AMP-DG-3,
6/18/1976
|
2 |
38 |
D-AMP-4,
8/26/1976
|
2 |
39 |
D-AMP-5,
8/26/1976
|
2 |
40 |
D-AMP-6,
9/17/1976
|
2 |
41 |
D-AMP-7,
12/23/1976
|
2 |
42 |
D-AMP-8,
12/23/1976
|
2 |
43 |
D-AMP-DG-101,
6/19/1976
|
2 |
44 |
D-AMP-102,
6/28/1976
|
2 |
45 |
D-AMP-103,
7/3/1976
|
2 |
46 |
D-AMP-104,
7/3/1976
|
2 |
47 |
D-AMP-105,
7/6/1976
|
2 |
48 |
D-AMP-106,
7/7/1976
|
2 |
49 |
D-AMP-107,
7/10/1976
|
2 |
50 |
D-AMP-108,
7/10/1976
|
2 |
51 |
D-AMP-109,
7/20/1976
|
2 |
52 |
GU-BR,
1976
|
3 |
1 |
L-AMP-DG-1,
6/12/1976
|
3 |
2 |
L-AMP-2,
10/22/1976
|
3 |
3 |
L-AMP-3,
12/20/1976
|
3 |
4 |
L-AMP-4,
12/21/1976
|
3 |
5 |
L-AMP-5,
12/22/1976
|
3 |
6 |
L-AMP-6,
12/22/1976
|
3 |
7 |
L-AMP-7,
12/23/1976
|
3 |
8 |
L-AMP-101,
7/12/1976
|
3 |
9 |
L-AMP-102,
7/12/1976
|
3 |
10 |
L-AMP-103,
7/15/1976
|
3 |
11 |
L-AMP-104,
7/17/1976
|
3 |
12 |
L-AMP-105,
7/17/1976
|
|
Antipyrine series,
1969-1976 [subseries]:
|
3 |
13 |
Antipyrine [ ]-CBF control 1,
3/29/1976
|
3 |
14 |
Antipyrine [ ]-CBF control 2,
4/2/1976
|
3 |
15 |
Antipyrine [ ]-CBF control 3,
4/3/1976
|
3 |
16 |
Antipyrine c14, [ ]-CBF control 4,
4/5/1976
|
3 |
17 |
Antipyrine c14, [ ]-CBF control 5,
4/6/1976
|
3 |
18 |
Antipyrine C14, [ ]-CBF control 6,
4/7/1976
|
3 |
19 |
Antipyrine partition coefficient in dogs,
1969-1970
|
3 |
20 |
Antipyrine partition coefficient in rats [photograph, negative],
1970
|
3 |
21 |
ARF-8A, LCBF-antip.-1', control,
1975
|
3 |
22 |
Chromatography on antipyrine,
undated
|
3 |
23 |
Laplace trsnaforms for antip. Sq. wave,
1975-1976
|
3 |
24 |
Series [ ] -- IOD: IODO-antip. part. coeff. in rats -- data corrected,
1976
|
3 |
25 |
Series [ ] -- IOD; IODO-antip. part. coeff. in rats -- discarded,
1976
|
3 |
26 |
Technical information on IODO-antipyrine,
1976
|
|
AR series,
1974-1975 [subseries]:
|
3 |
27 |
AR-1, P-30' -- 60 uc, experimental,
1974
|
3 |
28 |
AR-1A, P-30' -- 60 uc control,
1974
|
3 |
29 |
AR-2, P-30' -- 60 uc, experimentals,
1974
|
3 |
30 |
AR-3, P-30' -- 60 uc, experimentals,
1974
|
3 |
31 |
AR-3A, P-30' -- 60 uc, control,
1974
|
3 |
32 |
AR-4, P-30' -- 80 uc, experimentals,
1974
|
3 |
33 |
AR-4A, P-30' -- 80 uc, control,
1974
|
3 |
34 |
AR-5, P-30' -- 80 uc, experimentals,
1974
|
3 |
35 |
AR-5A, P-30' -- 80 uc, control,
1974
|
3 |
36 |
AR-6, P-30' -- 80 uc, experimentals,
1974
|
3 |
37 |
AR-6A, P-30' -- 80 uc, control,
1974
|
3 |
38 |
AR-7, P-30' -- 80 uc, experimentals,
1974
|
3 |
39 |
AR-8, P-30' -- 80 uc, experimentals,
1974
|
3 |
40 |
AR-9, anesthesia -- P-30' -- 80 uc, experimentals,
1974
|
3 |
41 |
AR-10, anesthesia -- P-30' -- 80 uc, experimentals,
1974
|
3 |
42 |
AR-11, experimentals,
11/6/1975
|
3 |
43 |
AR-12, experimentals,
12/6/1975
|
3 |
44 |
AR-13, experimentals,
7/16/1975
|
|
ARF series,
1974-1976 [subseries]:
|
3 |
45 |
ARF1 -- LCBF + BARB,
3/20/1974
|
3 |
46 |
ARF2 -- LCBF + BARB,
3/20/1974
|
3 |
47 |
ARF3 -- LCBF + BARB,
3/21/1974
|
3 |
48 |
ARF4 -- LCBF + BARB,
3/21/1974
|
3 |
49 |
ARF5, LCBF + BARB,
3/23/1974
|
3 |
50 |
ARF-6,
6/16/1975
|
3 |
51 |
ARF-7,
6/19/1975
|
3 |
52 |
ARF-8,
6/23/1975
|
3 |
53 |
ARF-11,
6/21/1976
|
3 |
54 |
ARF-12,
6/21/1976
|
3 |
55 |
ARF-13,
6/23/1976
|
3 |
56 |
ARF-14,
6/23/1976
|
3 |
57 |
ARF-15,
6/30/1976
|
3 |
58 |
ARF-16,
7/6/1976
|
|
ATP series,
1964-1973 [subseries]:
|
3 |
59 |
ATP assay protocol,
undated
|
3 |
60 |
ATP assays of factor preps.,
1966
|
3 |
61 |
Effects of thyroid hormone in vivo on protein biosynthesis -- book 1T,
1964
|
3 |
62 |
Effects of thyroxine in vivo [photographs, negatives],
undated
|
3 |
63 |
In vivo effect of T4 on microsomal ATP ase (I),
1971
|
3 |
64 |
In vivo effect of T4 on microsomal ATP ase (2),
1972
|
3 |
65 |
In vivo effect of T4/T3 on microsomal ATP ase (3),
1973
|
3 |
66 |
In vivo effect of T4/T3 on microsomal ATPase (4),
1973
|
4 |
1 |
In vivo experiments,
undated
|
4 |
2 |
Microsomal ATP ase -- prep book,
1970
|
4 |
3 |
Microsomal ATP ase 1,
Apr.-Oct. 1970
|
4 |
4 |
Microsomal ATP ase 2,
Oct. 1970
|
4 |
5 |
Microsomal ATP ase 3,
1971-1972
|
4 |
6 |
Microsomal ATP ase 4,
1972-1973
|
|
Cat series,
1971-1981 [subseries]:
|
4 |
7 |
Cat 1, LCGU 30',
1971
|
4 |
8 |
Cat 3, LCGU 35',
1971
|
4 |
9 |
Anest. Cat 4,
1974
|
4 |
10 |
Cat 101,
11/17/1977
|
4 |
11 |
Cat 102,
10/20/1977
|
4 |
12 |
Cat 103,
10/27/1977
|
4 |
13 |
Cat 104,
11/17/1977
|
4 |
14 |
Cat 105,
11/21/1977
|
4 |
15 |
Cat 106,
12/1/1977
|
4 |
16 |
Cat 107,
12/8/1977
|
4 |
17 |
Cat 108,
12/15/1977
|
4 |
18 |
Cat 109,
12/21/1977
|
4 |
19 |
Cat 110,
12/29/1977
|
4 |
20 |
Cat 111,
Jan. 12, 1978
|
4 |
21 |
Cat 112,
1/19/1978
|
4 |
22 |
Cat 113,
1/26/1978
|
4 |
23 |
Cat 114,
2/2/1978
|
4 |
24 |
Cat 115,
2/9/1978
|
4 |
25 |
Cat 116,
2/23/1978
|
4 |
26 |
Cat 117,
3/2/1978
|
4 |
27 |
Cat 118,
3/9/1978
|
4 |
28 |
Cat 119,
3/14/978
|
4 |
29 |
Cat 120,
3/16/1978
|
4 |
30 |
Cat 121,
3/23/1978
|
4 |
31 |
Cat 122,
3/24/1978
|
4 |
32 |
Cat 123,
3/28/1978
|
4 |
33 |
Cat 124,
3/29/1978
|
4 |
34 |
Cat awake, rem-4, rem-5, pc-1,
1980
|
4 |
35 |
Cat CBF 2,
1971
|
4 |
36 |
Cat, lumped constant,
1974
|
4 |
37 |
Normal cats, LCBF 1,
1971
|
4 |
38 |
Normal cat CBF 3,
1971
|
4 |
39 |
Normal cat CBF 4,
1971
|
4 |
40 |
Normal cat CBF 5,
1971
|
4 |
41 |
Normal -- CFG cat CBF 6,
1971
|
4 |
42 |
SC-1, r. eye patched + 1 PS (P-45' -- 200 uc),
1973
|
4 |
43 |
SC-1A, both eyes patched (P-45 -- 220 uc),
1973
|
4 |
44 |
Series cat: cats -- 30 min. controls,
1980-1981
|
4 |
45 |
Series SQ, Cat 2 -- 8 -- lumped constant in cats conscious,
1974-1976
|
4 |
46 |
SLC 1 (control for REM),
1975
|
4 |
47 |
SLC-2, control for REM,
1975
|
4 |
48 |
SLC-3, REM sleep cat,
1975
|
4 |
49 |
SLC-4, REM sleep cat,
1975
|
4 |
50 |
SLC-5, REM sleep cat,
1976
|
4 |
51 |
SQ -- Cat 1, anesth.,
1974
|
4 |
52 |
SQ -- Cat 2, anesth.,
1974
|
|
Cerebral Blood Flow (CBF) series,
1953-1993 [subseries]:
|
5 |
1 |
1 NMACO2 -- CBF series -- air breathing control,
1990
|
5 |
2 |
2 NMACO2 -- CBF series, air breathing control,
1990
|
5 |
3 |
3 NMACO2 -- CBF series, 5% CO2 in air,
1990
|
5 |
4 |
4 NMACO2 -- CBF series, 5% CO2 in air,
1990
|
5 |
5 |
5 NMACO2 -- CBF series -- 5% CO2 + N methyl arginine,
1990
|
5 |
6 |
6 NMACO2 -- CBF series -- 5% CO2 + N methyl arginine,
1990
|
5 |
7 |
7 NMACO2 -- CBF series, 5% C02 in air,
1990-1991
|
5 |
8 |
8 NMACO2 -- CBF series -- air breathing control,
1990
|
5 |
9 |
9 NMACO2 -- CBF series -- air + N methyl arginine,
1990
|
5 |
10 |
10 NMACO2 -- CBF series -- 5% CO2 + N methyl arginine,
1990
|
5 |
11 |
11 NMACO2 -- CBF series -- air + N methyl arginine,
1990-1991
|
5 |
12 |
12 NMACO2 -- CBF series -- 5% CO2 in air,
1990-1991
|
5 |
13 |
13 NMACO2 -- CBF series -- 5% CO2 in air,
1990-1991
|
5 |
14 |
14 NMACO2 -- CBF series -- 5% CO2 in air,
1990-1991
|
5 |
15 |
15 NMACO2 -- CBF series -- air + N methyl arginine,
1991
|
5 |
16 |
16 NMACO2 -- CBF series -- air breathing control,
1991
|
5 |
17 |
17 NMACO2 -- CBF series -- air + N methyl arginine,
1991
|
5 |
18 |
18 NMACO2 -- CBF series -- 5% CO2 + N methyl arginine,
1991
|
5 |
19 |
19 NMACO2 -- CBF series -- air breathing control,
1991
|
5 |
20 |
20 NMACO2 -- CBF series -- air + N methyl arginine,
1991
|
5 |
21 |
21 NMACO2 -- CBF series -- 5% CO2 + N methyl arginine,
1991
|
5 |
22 |
22 NMACO2 -- CBF series -- air + N methyl arginine,
1991
|
5 |
23 |
23 NMACO2 -- CBF series -- 5% CO2 in air,
1991
|
5 |
24 |
24 NMACO2 -- CBF series -- 5% CO2 + N methyl arginine,
1991
|
5 |
25 |
25 NMACO2 -- CBF series -- air breathing control,
1991
|
5 |
26 |
26 NMACO2 -- CBFG series -- air + N methyl arginine,
1991
|
5 |
27 |
27 NMACO2 -- CBF series -- 5% CO2 + N methyl arginine,
1991
|
5 |
28 |
28 NMACO2 -- CBF series -- 5% CO2 + N methyl arginine,
1991
|
5 |
29 |
29 NMACO2 -- CBF series -- 5% CO2 + N methyl arginine (30 mg/kg),
1991
|
5 |
30 |
30 NMACO2 -- CBF series -- - 5% CO2 + N methyl arginine (30 mg/kg),
1991
|
5 |
31 |
31 NMACO2 -- CBF series -- air + N methyl arginine (30 mg/kg),
1991
|
5 |
32 |
32 NMACO2 -- CBF series -- air + N methyl arginine (30 mg/kg),
1991
|
5 |
33 |
33 NMACO2 -- CBF series -- air + N methyl arginine (30 mg/kg),
1991
|
5 |
34 |
34 NMACO2 -- CBF series -- 5% CO2 + N methyl arginine (30 mg/kg),
1991
|
5 |
35 |
35 NMACO2 -- CBF series -- 5% CO2 + N methyl arginine (30 mg/kg),
1991
|
5 |
36 |
36 NMACO2 -- CBF series -- air + N methyl arginine (30 mg/kg),
1991
|
5 |
37 |
37 NMACO2 -- CBF series -- air + N methyl arginine (30 mg/kg),
1991
|
5 |
38 |
38 NMACO2 -- CBF series -- air + N methyl arginine (30 mg/kg),
1991
|
5 |
39 |
39 NMACO2 -- CBF series -- air + saline,
1991
|
5 |
40 |
40 NMACO2 -- CBF series -- 5% CO2 + N methyl arginine (100 mg/kg),
1991
|
5 |
41 |
41 NMACO2 -- CBF series -- 5% CO2 + N methyl arginine,
1991
|
5 |
42 |
42 NMACO2 -- CBF series -- air + N methyl arginine (100 mg/kg),
1991
|
5 |
43 |
43 NMACO2 -- CBF series -- air + NMA (100 mg/kg),
1991
|
5 |
44 |
44 NMACO2 -- CBF series -- 5% CO2 + NMA (100 mg/kg),
1991
|
5 |
45 |
45 NMACO2 -- CBF series -- 5% CO2 + NMA (100 mg/kg),
1991
|
5 |
46 |
46 NMACO2 -- CBF series -- air + NMA (100 mg/kg),
1991
|
5 |
47 |
47 NMACO2 -- CBF series -- air + NMA (100 mg/kg),
1991
|
5 |
48 |
48 NMACO2 -- CBF series -- 5% CO2 + NMA (100 mg/kg),
1991
|
5 |
49 |
49 NMACO2 -- CBF series -- 5% CO2 + NMA (100 mg/kg),
1991
|
5 |
50 |
50 NMACO2 -- CBF series -- air + NMA (100 mg/kg),
1991
|
5 |
51 |
51 NMACO2 -- CBF series -- air + NMA (100 mg/kg),
1991
|
5 |
52 |
52 NMACO2 -- CBF series -- 5% CO2 + NMA (100 mg/kg),
1991
|
5 |
53 |
53 NMACO2 -- CBF series -- air + NMA (100 mg/kg),
1991
|
5 |
54 |
54 NMACO2 -- CBF series -- air + saline,
1991
|
5 |
55 |
55 NMACO2 -- CBF series -- air + saline (eliminated),
1991
|
5 |
56 |
56 NMACO2 -- CBF series -- air + saline,
1991
|
5 |
57 |
57 NMACO2 -- CBF series -- air breathing control,
1991
|
5 |
58 |
58 NMACO2 -- CBF series -- 5% CO2 in air,
1991
|
5 |
59 |
59 NMACO2 -- CBF series -- 5% CO2 in air,
1991
|
5 |
60 |
60 NMACO2 -- CBF series -- air breathing control,
1991
|
5 |
61 |
61 NMACO2 -- CBF series -- air breathing control,
1991
|
5 |
62 |
62 NMACO2 -- CBF series -- 5% CO2 in air,
1991
|
5 |
63 |
63 NMACO2 -- CBF series -- saline + 5% CO2,
1991
|
5 |
64 |
64 NMACO2 -- CBF series -- saline + air,
1991
|
5 |
65 |
65 NMACO2 -- CBF series -- saline + air,
1991
|
5 |
66 |
66 NMACO2 -- CBF series -- saline + 5%CO2,
1991
|
5 |
67 |
67 NMACO2 -- CBF series -- air + NMA (30 mg/kg),
1991
|
5 |
68 |
68 NMACO2 -- CBF series -- air + NMA (10 mg/kg),
1991
|
5 |
69 |
69 NMACO2 -- CBF series --5% CO2 + NMA (10 mg/kg),
1991
|
5 |
70 |
70 NMACO2 -- CBF series -- air + NMA (10 mg/kg),
1991
|
5 |
71 |
71 NMACO2 -- CBF series -- 5% CO2 + NMA (10 mg/kg),
1991
|
5 |
72 |
72 NMACO2 -- CBF series -- air + NMA (10 mg/kg),
1991
|
5 |
73 |
NMA-73, NMA 10 mg/kg + air,
1992
|
5 |
74 |
NMA-74, NMA 10 mg/kg I.V + air,
1992
|
5 |
75 |
NMA-75, NMA 30 mg/kg I.V. + air,
1992
|
5 |
76 |
NMA-76, NMA 10 mg/kg I.V. + 5% CO2,
1992
|
5 |
77 |
77 NTRO-1, CO2 and saline I.V.,
1992
|
5 |
78 |
78 NTRO-2, CO2 and nitro,
1992
|
5 |
79 |
79 NTRO-3, air and nitro 30 mg/kg i.v.,
1992
|
5 |
80 |
80 NTRO-4, air and nitro,
1992
|
5 |
81 |
81 NTRO-5, CO2 and nitro,
1992
|
5 |
82 |
82 NTRO-6, CO2 and saline i.v.,
1992
|
5 |
83 |
83 NTRO-7, CO2 and saline i.v.,
1992
|
6 |
1 |
84 NTRO-8, CO2 and nitro,
1992
|
6 |
2 |
85 NTRO-9, air and nitro,
1992
|
6 |
3 |
86 NTRO-10, CO2 and nitro 30 mg/kg i.v.,
1992
|
6 |
4 |
87 NTRO-11, air + nitro 30 mg/kg i.v.,
1992
|
6 |
5 |
88 NTRO-12, CO2 and nitro 30 mg/kg i.v.,
1992
|
6 |
6 |
89 NTRO-13, air and nitro,
1992
|
6 |
7 |
90 NTRO-14, air and nitro,
1992
|
6 |
8 |
91 NTRO-15, CO2 and nitro,
1992
|
6 |
9 |
92 NTRO-16, CO2 and nitro,
1992
|
6 |
10 |
93 NTRO-17, 5% CO2 and nitro 30 mg/kg,
1992
|
6 |
11 |
95 NTRO-19, 5% CO2 and nitro 30 mg/kg i.v.,
1992
|
6 |
12 |
96 NTRO-20, nitro-topical,
1992
|
6 |
13 |
97 NTRO-21, nitro-topical,
1992
|
6 |
14 |
98 NTRO-22, nitro-topical,
1992
|
6 |
15 |
98 NTRO-23, nitro-topical,
1992
|
6 |
16 |
100 NTRO-24s, air and nitro 30 mg/kg,
1993
|
6 |
17 |
101 NTRO-25s, air + nitro 30 mg/kg,
1993
|
6 |
18 |
102 NTRO-26s, 5% CO2 and nitro 30 mg/kg i.v.,
1993
|
6 |
19 |
103 NTRO-27s, nitro 30 mg/g i.v. and 5% CO2,
1993
|
6 |
20 |
104 (28), CO2 and NTRO,
1993
|
6 |
21 |
105 (29), CO2 and NTRO,
1993
|
6 |
22 |
106 (30), air and NTRO,
1993
|
6 |
23 |
107 (31), air and NTRO,
1993
|
6 |
24 |
NTRO 108, chronic i.p. and CO2,
1993
|
6 |
25 |
NTRO 109, chronic i.p. and CO2,
1993
|
6 |
26 |
NTRO 110, chronic i.p. and air,
1993
|
6 |
27 |
NTRO 111, chronic i.p. and air,
1993
|
6 |
28 |
NTRO 112, chronic i.p. and air,
1993
|
6 |
29 |
NTRO 113, chronic i.p. and CO2,
1993
|
6 |
30 |
NTRO 114, chronic i.p. and CO2,
1993
|
6 |
31 |
NTRO 115, chronic i.p. and CO2,
1993
|
6 |
32 |
NTRO 116, chronic i.p. and air,
1993
|
6 |
33 |
NTRO 117, chronic i.p. and air,
1993
|
6 |
34 |
NTRO 118, chronic i.p. and air,
1993
|
6 |
35 |
NTRO 119, chronic i.p. and CO2,
1993
|
6 |
36 |
NTRO 120, saline chronic i.p. and CO2,
1993
|
6 |
37 |
NTRO 121, saline chronic i.p. and CO2,
1993
|
6 |
38 |
NTRO 122, saline chronic i.p. and air,
1993
|
6 |
39 |
NTRO 123, saline chronic i.p. and air,
1993
|
6 |
40 |
NTRO 124, saline chronic i.p. and air,
1993
|
6 |
41 |
NTRO 125, saline chronic i.p. and CO2,
1993
|
6 |
42 |
NTRO 126,
1993
|
6 |
43 |
NTRO 127,
1993
|
6 |
44 |
NTRO 128,
1993
|
6 |
45 |
NTRO 129,
1993
|
6 |
46 |
NTRO 130,
1993
|
6 |
47 |
NTRO 131, saline chronic i.p. and CO2,
1993
|
6 |
48 |
NTRO 132, saline chronic i.p. and CO2,
1993
|
6 |
49 |
NTRO 133, saline chronic i.p. and CO2,
1993
|
6 |
50 |
14c-NMA distribution,
1993
|
6 |
51 |
Brain tissue NMA assay,
1992
|
6 |
52 |
Calculations for CBF (Kety-Schmidt),
undated
|
6 |
53 |
CBF -- ischemia experiments,
1980
|
6 |
54 |
CBF -- LSD -- normals,
1954-1955
|
6 |
55 |
CBF -- n.20 -- normal young,
1957-1958
|
6 |
56 |
CBF -- nitrous oxide -- Pitressin,
1956
|
6 |
57 |
CBF -- nitrous oxide -- children [photographs],
1957
|
6 |
58 |
CBF -- thyroid disease,
undated
|
6 |
59 |
CBF aged -- continued,
1956-1957
|
6 |
60 |
CBF exp.,
undated
|
6 |
61 |
CBF lysergic acid [photographs],
1955
|
6 |
62 |
Cerebral blood flow,
1957-1958
|
6 |
63 |
Cerebral blood flow -- book II,
1954-1957
|
6 |
64 |
Cerebral blood flow 3,
1955
|
6 |
65 |
Changes in CBF during REM sleep (fig. 3) (from Reivitch, et. al.) [slides],
1977
|
6 |
66 |
Chemical assay in NMA study,
1992
|
6 |
67 |
CO2 study -- local CBF,
undated
|
6 |
68 |
CBF -- LSD -- schizophrenia,
1954-1955
|
6 |
69 |
KR 79 CBF studies [photographs],
1953-1955
|
6 |
70 |
Local C.B.F III,
1954-1955
|
6 |
71 |
Local C.B.F. II,
1953-1954
|
6 |
72 |
Local C.B.V IV,
1955-1957
|
152 |
16 |
Hyperthyroids/hypothyroids,
1950-1951
|
152 |
17 |
[Thyroid hormones],
[c.1950s]
|
152 |
18 |
Norepinephrine studies,
1950-1951
|
152 |
19-20 |
The role of L-Norepinephrine in the treatment of shock,
1953
|
152 |
21 |
Sleep paper,
[1952-1953]
|
152 |
22 |
Sleep study,
[1950-1951]
|
152 |
23 |
Cerebral blood flow mental exercises,
[1952-1954]
|
6 |
73 |
NMA Co2 series,
undated
|
6 |
74 |
NMA2DG series: animal 01 control,
1991
|
6 |
75 |
NMA2DG series: animal 02, exp. NMA 3 mg.,
1991
|
6 |
76 |
NMA2DG series: animal 3, exp. NMA 3 mg/kg,
1991
|
6 |
77 |
NMA2DG series: animal 4 control,
1991
|
6 |
78 |
NMA2DG series: animal 05, exp. NMA 3mg/kg,
1991
|
6 |
79 |
NMA2DG series: animal 06 control,
1991
|
6 |
80 |
NMA2DG series: animal 07, exp. NMA 3mg/kg,
1991
|
6 |
81 |
NMA2DG series: animal 08 control,
1991
|
6 |
82 |
NMA2DG series: animal 09 control,
1991
|
6 |
83 |
NMA2DG series: animal 10 control (eliminated),
1991
|
7 |
1 |
NMA2DG series: animal 11 control,
1991
|
7 |
2 |
NMA2DG series: animal 12 control,
1991
|
7 |
3 |
NMA2DG series: animal 13 control,
1991
|
7 |
4 |
NMA2DG series: animal 14, exp. NMA 100 mg/kg,
1991
|
7 |
5 |
NMA2DG series: animal 15, exp. NMA 100 mg/kg,
1991
|
7 |
6 |
NMA2DG series: animal 16 control,
1991
|
7 |
7 |
NMA2DG series: animal 17, exp. NMA 100 mg/kg,
1991
|
7 |
8 |
NMA2DG series: animal 18 control,
1991
|
7 |
9 |
NMA2DG series: animal 19, exp. NMA 100 mg/kg,
1991
|
7 |
10 |
NMA2DG series: animal 20, exp. NMA 100 mg/kg,
1991
|
7 |
11 |
NMA2DG series: animal 21, exp. NMA 100 mg/kg,
1991
|
7 |
12 |
NMACO2 summaries,
1992
|
7 |
13 |
NMA-DG, data sheet,
1991-1992
|
7 |
14 |
Regional cerebral blood flow (Tbl 2) (from Reivitch, et. al.),
1977
|
|
CI* series,
undated
|
7 |
15 |
Ci *(t)/Cp*(t) v.s stretch time (pulse experiments),
1979
|
7 |
16 |
Ci ct/Cp* vs. real time or stretch time -- weighted average,
1979-1985
|
7 |
17 |
Ci*(t)/Cp*(t) vs. stretch time (pulse experiments),
undated
|
7 |
18-19 |
Local tissue 14c concentration (gray) Ci*Ct/Cp* (gray) [folder 1 of 2],
1979-1986
|
7 |
20 |
Local tissue 14c concentration (white) -- Ci ct/Cp* (white),
1975-1985
|
7 |
21 |
Lt Cp*dt -- pulse exp.,
1979
|
7 |
22 |
Pulse (mori) -- local Ci* -- ci*/Cp*,
1979-1984
|
7 |
23 |
Square wave experiments -- Ci*(t)/Cp*(t) vs. stretch time -- vs. real time Ci*(t)/Cp*,
undated
|
7 |
24 |
Weighted average -- Ci*(t)/Cp*(t) vs. stretch time -- pulse experiments,
1979
|
|
CR series,
1972-1976 [subseries]:
|
7 |
25 |
CB-4, B-20 uc -- 45', CO2 -- 86',
1975
|
7 |
26 |
CB-5, B-20 uc -- 45', CO2 -- 86',
1975
|
7 |
27 |
CB-6, Pul. -- 20 uc -- 45', CO2 -- 90',
1975
|
7 |
28 |
CB-7, LCGU-45' -- 30 uc, CO2 -- 75',
1975
|
7 |
29 |
CB-8, discarded,
1975
|
7 |
30 |
CB-9, LCGU -- 45' -- 30 uc, CO2 -- 75',
1975
|
7 |
31 |
Series CRO: 5% CO2, 45' exposure,
undated
|
7 |
32 |
CR-1, LCGU + CO2, P-30' 80 uc,
1974
|
7 |
33 |
CR-2, LCGU + CO2, P-30' -- 80 uc,
1974
|
7 |
34 |
CR-3, LCGU + CO2, P-30' -- 80 uc,
1974
|
7 |
35 |
CR-4, LCGU + CO2, P-33' -- 90 uc,
1974
|
7 |
36 |
CR-5, LCGU + CO2, P-30' -- 90 uc,
1974
|
7 |
37 |
CR-101, LCGU -- 30' -- 75 uci, CO2 -- 45',
1975
|
7 |
38 |
CR-102, LCGU -- 30' -- 75 uci, CO2 -- 45',
1975
|
7 |
39 |
CR-103, LCGU -- 30' -- 75 uci, CO2 -- 45',
1975
|
7 |
40 |
CR-104, LCGU -- 30' -- 50 uci, CO2 -- 45',
1975
|
7 |
41 |
CR-105, LCGU -- 30' -- 70 uci, CO2 -- 45',
1975
|
7 |
42 |
CRF-1, 85 uc, LCBF + CO2-74 min.,
1974
|
7 |
43 |
CRF-2, 85 uc, LCBF + CO2 -- 70',
1974
|
7 |
44 |
CRF-3, 85 uc, LCBF + CO2 -- 45',
1974
|
7 |
45 |
CRF-4, 68 uc, LCBF + CO2 -- 48',
1974
|
7 |
46 |
CRF-5, 68 uc, LCBF + CO2 -- 45',
1974
|
7 |
47 |
CRF-6, 85 uc, LCBF + CO2 -- 41',
1974
|
7 |
48 |
CRF-7, 85 uc, LCBF + CO2 -- 26',
1974
|
7 |
49 |
CRF-8, 85 uc, LCBF + CO2 -- 38',
1974
|
7 |
50 |
CRF-9, 85 uc, LCBF + CO2 -- 43',
1974
|
7 |
51 |
CRF-10, 85 uc, LCBF + CO2 -- 42',
1974
|
7 |
52 |
CRF-11, 85 uc, LCBF + CO2 -- 11',
1975
|
7 |
53 |
CRF-12, 85 uc, LCBF + CO2 -- 12',
1975
|
7 |
54 |
CRF-13, 85 uc, LCBF + CO2 -- 12',
1975
|
7 |
55 |
CRF-14, 85 uc, LCBF + CO2 -- 16',
1975
|
7 |
56 |
CRF-15, 68 uc, LCBF + CO2 -- 14',
1975
|
7 |
57 |
CRF-101, LCBF -- 1', 10% CO2 -- 45',
1975
|
7 |
58 |
CRF-102, LCBF -- 1', 10% CO2 -- 45',
1975
|
7 |
59 |
CRF-103, LCBF -- 1', 10% CO2 -- 45',
1975
|
7 |
60 |
CRF-104, LCBF -- 1', 10% CO2 -- 45',
1975
|
7 |
61 |
CRF-105, LCBF (Ant. 1'), 10% CO2 -- 45',
1975
|
7 |
62 |
Series CRF 111-115 : 10% CO2 + 10' exposure,
1975
|
7 |
63 |
CRF-201, 20% CO2,
1976
|
7 |
64 |
L.C.B.F. : effects of CO2 in puppy,
1972
|
|
DEX series,
1979 [subseries]:
|
8 |
1 |
Dex-1,
1/30/1979
|
8 |
2 |
Dex-2,
3/12/1979
|
8 |
3 |
Dex-3,
3/14/1979
|
8 |
4 |
Dex-4,
3/16/1979
|
8 |
5 |
Dex-5,
4/19/1979
|
8 |
6 |
Dex-Px-1 (21 mg/kg),
1/15/1979
|
8 |
7 |
Dex-Px-2 (21 mg/kg),
3/12/1979
|
8 |
8 |
Dex-Px-3 (21 mg/kg/min.),
3/14/1979
|
8 |
9 |
Dex-Px-4 (21 mg/kg),
3/16/1979
|
8 |
10 |
Dex-Px-5 (21 mg/kg),
3/21/1979
|
|
Deoxyglucose (DG) series,
1973-1979 [subseries]:
|
8 |
11 |
% of free DG in grey and white matter,
1977
|
8 |
12 |
DG-1, 30' -- B,
1973
|
8 |
13 |
DG-2 (C14),
1973
|
8 |
14 |
DG-3, 45' cont.,
1973
|
8 |
15 |
DG-101, 30' -- B,
1973
|
8 |
16 |
DG-102, B -- 30' -- 51 uc,
1973
|
8 |
17 |
DG-103, B-45'-76 uc,
1973
|
8 |
18 |
DG-104, B-45' -- 76 uc,
1973
|
8 |
19 |
DG-105 B-120' (51 uc x 1 1/2'),
1973
|
8 |
20 |
DG-106, B-45' -- 51 uc,
1973
|
8 |
21 |
DG-107 B-120 (51 uc x 1 1/2'),
1973
|
8 |
22 |
DG-108, B-45' -- 51 uc,
1973
|
8 |
23 |
DG-111, B-75' -- 51 uc,
1973
|
8 |
24 |
DG-112, B-75 -- 51 uc,
1973
|
8 |
25 |
DG-113, B-90' -- 51 uc,
1973
|
8 |
26 |
DG-114, B-90' -- 51 uc,
1973
|
8 |
27 |
DG-115, LCGU -- control 45',
1975
|
8 |
28 |
DG-116, LCGU -- control 45' (30 uc),
1975
|
8 |
29 |
DG-117, LCGU -- 30' -- 50 uc,
1975
|
8 |
30 |
DG-118, LCGU -- 30', control,
1975
|
8 |
31 |
DG-119, LCGU -- 30' -- 50 uc, control,
1975
|
8 |
32 |
DG-120, LCGU -- 30' -- 50 uc, control,
1975
|
8 |
33 |
DG-121, normal control 45',
1976
|
8 |
34 |
DG-125, LCGU normal control rat, 30',
1976
|
8 |
35 |
DG-126, LCGU -- normal control rat 45',
1976
|
8 |
36 |
DG-127, LCGU -- normal control, 45',
1976
|
8 |
37 |
DG-128, LCGU -- normal control rat, 45',
1976
|
8 |
38 |
DG-129, LCGU -- normal control rat, 45',
1976
|
8 |
39 |
DG-130, LCGU -- normal control, 30',
1976
|
8 |
40 |
DG-131, LCGU -- normal control, 30',
1976
|
8 |
41 |
DG-132, LCGU normal control, 30',
1976
|
8 |
42 |
DG-133, LCGU -- normal control, 30',
1976
|
8 |
43 |
DG-134, LCGU -- normal control rat, 45' (discarded),
1976
|
8 |
44 |
DG-135, LCGU -- light flow rate of anesthetic gas mixture, 45',
1976
|
8 |
45 |
DG-137, LCGU -- tight mask + high flow rate of anesthetic gas mixture, 30',
1976
|
8 |
46 |
DG-138, normal control rat, 45',
1976
|
8 |
47 |
DG-141, high flow rate of gas mix with tight mask, 30',
1976
|
8 |
48 |
DG-142, low flow rate of gas mix with loose mask, 30',
1976
|
8 |
49 |
DG-143, normal control rat, 45',
1976
|
8 |
50 |
DG-144, normal control rat, 45',
1976
|
8 |
51 |
DG-145, normal control rat, 45',
1976
|
8 |
52 |
DG-146, normal control rat, 45',
1976
|
8 |
53 |
DG-147, normal control rat, 45' (discarded),
1976
|
8 |
54 |
DG-170,
8/16/1977
|
8 |
55 |
DG-182, 45 min. (C.K.),
7/27/1978
|
8 |
56 |
DG-183, 30 min. (C.K.),
7/27/1978
|
8 |
57 |
DG-184, 20 min. C.K.,
7/27/1978
|
8 |
58 |
DG-185, 45 m in. (C.K.),
7/31/1978
|
8 |
59 |
DG-186, 30 min. (C.K.),
7/31/1978
|
8 |
60 |
DG-190, 45 min. (C.K.),
9/11/1978
|
8 |
61 |
DG-191, 20' control,
9/11/1978
|
8 |
62 |
DG-192, 60 min. (C.K.),
9/14/1978
|
8 |
63 |
DG-193, 45 min. (C.K.),
9/18/1978
|
8 |
64 |
DG-194, 90 min. (C.K.),
9/21/1978
|
8 |
65 |
DG-195, 20 min. C.K.,
9/21/1978
|
8 |
66 |
DG-196, 20 min. C.K.,
10/2/1978
|
8 |
67 |
DG-198, 30 min. (C.K.),
10/5/1978
|
8 |
68 |
DG-199, 20 min. C.K.,
10/16/1978
|
9 |
1 |
DG-200, 30 min (C.K.),
10/16/1978
|
9 |
2 |
DG-201, 45 min. (C.K.),
10/19/1978
|
9 |
3 |
DG-201, 5' -- C -- 51 uc,
1973
|
9 |
4 |
DG-202, 60 min (C.K.),
10/19/1978
|
9 |
5 |
DG-202., 5' -- C -- 51 uc,
1973
|
9 |
6 |
DG-203, 10' -- C 39 uc,
1973
|
9 |
7 |
DG-203, 90 min.,
10/23/1978
|
9 |
8 |
DG-204, 10' -- C 39 uc,
1973
|
9 |
9 |
DG-204, 60 min.,
10/23/1978
|
9 |
10 |
DG-205, 10' -- C -- 39 uc,
1973
|
9 |
11 |
DG-205, 60 min. control,
1978
|
9 |
12 |
DG-206, 5' -- C 51 uc,
1973
|
9 |
13 |
DG-207, 10' -- C -- 39 uc,
1973
|
9 |
14 |
DG-207, 60 min.,
12/22/1978
|
9 |
15 |
DG-208, 20' -- C -- 34 uc,
1973
|
9 |
16 |
DG-209, 20' -- C -- 34 uc,
1973
|
9 |
17 |
DG-209, 45 min. (C.K.),
12/28/1978
|
9 |
18 |
DG-210, 20' -- C -- 34 uc,
1973
|
9 |
19 |
DG-210, 30 min.,
12/28/1978
|
9 |
20 |
DG-211, 20 min. control,
1/4/1979
|
9 |
21 |
DG-211, C -- 30' -- 29 uc,
1973
|
9 |
22 |
DG-212, 30' -- C -- 29 uc,
1973
|
9 |
23 |
DG-212, 90 min.,
1/11/1979
|
9 |
24 |
DG-213, 90 min.,
1/15/1979
|
9 |
25 |
DG-213, C -- 30' -- 29 uc,
1973
|
9 |
26 |
DG-214, 90 min.,
1/18/1979
|
9 |
27 |
DG-214, C -- 45' -- 23 uc,
1973
|
9 |
28 |
DG-215, 90 min.,
1/18/1979
|
9 |
29 |
DG-215, C -- 45' -- 23 uc,
1973
|
9 |
30 |
DG-216, C -- 1' -- 68 uc,
1973
|
9 |
31 |
DGX-1, BoP. -- 6 hrs.,
1973
|
9 |
32 |
DGX-2, BoP. -- 17 hrs.,
1973
|
9 |
33 |
DGX-3, BoP -- 24 hrs.,
1973
|
9 |
34 |
Summary of DGX-1, DGX-2, DGX-3 data,
1973
|
151 |
4 |
[DG* and DG*-6-P chart with three time graph printouts,
1974, 1975, 1976
|
|
DL series,
1971-1973 [subseries]:
|
9 |
35 |
DL-X,
1972
|
9 |
36 |
Series DL1 -- DL11 : 20 mg/kg, experimentals,
1971
|
9 |
37 |
Series DL 1A -- DL 11A : 20 mg/kg controls,
1972
|
9 |
38 |
Series DL101 -- DL110 : 100 mg/kg, experimentals,
1971
|
9 |
39 |
Series DL201-DL206 : 50 mg/kg, experimental,
1972
|
9 |
40 |
Series DL207A -- DL215A : 50 mg/kg, controls,
1972
|
9 |
41 |
Series DL208 -- DL211 : 50 mg/kg, experimentals,
1972
|
9 |
42 |
Series DL213 -- DL214 : 50 mg/kg, experimentals,
1975
|
9 |
43 |
Series DL301 and DL302 : 50 mg/kg, experimental,
1972
|
9 |
44 |
Series DL301A -- DL303A : 50 mg/kg, controls,
1972
|
9 |
45 |
Series DL304 -- DL307 : 50 mg/kg, experimentals,
1972
|
9 |
46 |
Series DL306A -- DL309A : 50 mg/kg, controls,
1972-1973
|
9 |
47 |
Series DL-309 : 50 mg/kg, experimentals,
1973
|
|
E/E series,
1974-1975 [subseries]:
|
9 |
48 |
E/E 1and2, discarded,
1974
|
9 |
49 |
E/E 3,
1974
|
9 |
50 |
E/E 4,
1974
|
9 |
51 |
E/E 5,
1974
|
9 |
52 |
E/E 6,
1974
|
9 |
53 |
Rat E/E 7,
1974
|
9 |
54 |
E/E 8,
11/7/1974
|
9 |
55 |
E/E 9,
11/14/1974
|
9 |
56 |
E/E 10,
12/12/1974
|
9 |
57 |
E/E 11,
1974
|
9 |
58 |
E/E 12,
1974
|
9 |
59 |
E/E 13,
Jan. 10, 1975
|
9 |
60 |
E/E 14,
1/13/1975
|
9 |
61 |
E/E 15,
1/17/1975
|
9 |
62 |
E/E 16,
1/23/1975
|
9 |
63 |
E/E 17,
1/27/1975
|
9 |
64 |
E/E 18,
2/6/1975
|
9 |
65 |
E/E 19,
2/10/1975
|
9 |
66 |
E/E 20,
2/13/1975
|
9 |
67 |
E/E 21,
Feb. 14, 1975
|
9 |
68 |
E/E 26, and 27, cancelled,
1975
|
9 |
69 |
E/E 29 discarded,
1975
|
|
G6 series,
1985, 1987 [subseries]:
|
9 |
70 |
G6 pase 1,
1985
|
9 |
71 |
G6 pase 2,
1985
|
9 |
72 |
G6 pase 3,
1985
|
9 |
73 |
G6 pase 4,
1985
|
9 |
74 |
G6 pase 5,
1985
|
9 |
75 |
G6 pase 6,
1985
|
9 |
76 |
GA pase 7,
1985
|
9 |
77 |
G6 pase 8,
1985
|
9 |
78 |
G6 pase 9,
1985
|
9 |
79 |
G6 pase 10,
1985
|
9 |
80 |
G6 pase 11,
1985
|
9 |
81 |
G6 pase 12,
1985
|
9 |
82 |
G6 pase 13,
8/2/1985
|
9 |
83 |
G6 pase 14,
1985
|
9 |
84 |
G6 pase 15,
1985
|
9 |
85 |
G6 pase 16,
1985
|
9 |
86 |
G6 0ase 17,
8/5/1985
|
9 |
87 |
G6 pase 18,
8/5/1985
|
9 |
88 |
G6 pase 19,
8/5/1985
|
9 |
89 |
G6 pase 20,
8/5/1985
|
9 |
90 |
G6 pase 21,
8/1/1985
|
9 |
91 |
G6 pase 22,
8/6/1985
|
9 |
92 |
G6 pase 23,
8/6/1985
|
9 |
93 |
G6 pase 24,
8/6/1985
|
9 |
94 |
G6 pase 25,
8/7/1985
|
9 |
95 |
G6 pase 26,
8/7/1985
|
9 |
96 |
G6 pase 27,
8/7/1985
|
9 |
97 |
G6 pase 28,
8/7/1985
|
9 |
98 |
G6 pase 29,
8/8/1985
|
10 |
1 |
G6 pase 30,
8/8/1985
|
10 |
2 |
G6 pase 31,
8/8/1985
|
10 |
3 |
G6 pase 32,
8/8/1985
|
10 |
4 |
G6 pase 33,
8/9/1985
|
10 |
5 |
G6 pase 34,
8/9/1985
|
10 |
6 |
G6 pase 35,
8/9/1985
|
10 |
7 |
G6 pase 36,
8/9/1985
|
10 |
8 |
G6 pase 37,
8/10/1985
|
10 |
9 |
G6 pase 38,
8/10/1985
|
10 |
10 |
G6 pase 39,
1985
|
10 |
11 |
G6 pase 40,
1985
|
10 |
12 |
G6 pase 41,
1985
|
10 |
13 |
G6 pase 42 -- 60 min.,
8/13/1985
|
10 |
14 |
G6 pase 43,
1985
|
10 |
15 |
G6 pase 44,
8/14/1985
|
10 |
16 |
G6 pase 45 -- 90 min.,
8/14/1985
|
10 |
17 |
G6 pase 46 -- 2.5 min.,
8/14/1985
|
10 |
18 |
G6 pase 47 -- 15 min.,
8/14/1985
|
10 |
19 |
G6 pase 48 -- 60 min.,
8/16/1985
|
10 |
20 |
G6 pase 49 -- 30 min.,
8/16/1985
|
10 |
21 |
G6 pase 50 -- 15 min.,
8/16/1985
|
10 |
22 |
G6 pase 51,
8/17/1985
|
10 |
23 |
G6 pase 52,
10/16/1985
|
10 |
24 |
G6 pase 53,
10/16/1985
|
10 |
25 |
G6 pase 54,
11/27/1985
|
10 |
26 |
G6 pase 55,
11/27/1985
|
10 |
27 |
G6 pase 56,
11/29/1985
|
10 |
28 |
G6 pase 57,
11/29/1985
|
10 |
29 |
G6 pase 58,
11/29/1985
|
10 |
30 |
G6 pase P1,
8/15/1985
|
10 |
31 |
G6 pase P2,
8/15/1985
|
10 |
32 |
G6 pase P3,
8/16/1985
|
10 |
33 |
G6 pase P4,
8/16/1985
|
10 |
34 |
G6 pase P5,
8/16/1985
|
10 |
35 |
G6 pase P6,
8/27/1985
|
10 |
36 |
G6 pase P7,
8/1985
|
10 |
37 |
G6 pase,
1985
|
10 |
38 |
G6 pase -- vol. I -- no. 1 -- no. 13,
1985
|
10 |
39 |
G6 pase -- vol. II -- no. 14 -- no. 25,
1985
|
10 |
40 |
G6 pase -- vol. III -- no. 26 -- no. 37,
1985
|
10 |
41 |
G6 pase -- vol. IV -- no. 38 -- no. 49,
1985
|
10 |
42 |
G6 pase -- P -- vol V,
1985
|
10 |
43 |
G6 pase -- vol. VI -- no. 50,
1985
|
10 |
44 |
G6 pase (square) -- anova,
1987
|
10 |
45 |
Physiological conditions -- G6 pase 1~58,
undated
|
|
HLNC series,
1976 [subseries]:
|
10 |
46 |
Helen and Larry normal control series,
undated
|
10 |
47 |
HLNC-DG-,
6/25/1976
|
10 |
48 |
HLNC-DG-2, discarded,
6/25/1976
|
10 |
49 |
HLNC-3,
6/28/1976
|
10 |
50 |
HLNC-4,
7/1/1976
|
10 |
51 |
HLNC-5,
7/2/1976
|
10 |
52 |
HLNC-6,
7/6/1976
|
10 |
53 |
HLNC-7,
7/10/1976
|
10 |
54 |
HLNC-8,
8/24/1976
|
10 |
55 |
HLNC-9,
8/24/1976
|
10 |
56 |
HLNC-10,
10/22/1976
|
10 |
57 |
HLNC-11,
12/18/1976
|
10 |
58 |
HLNC-12,
12/18/1976
|
10 |
59 |
HLNC-13,
12/20/1976
|
10 |
60 |
HLNC-14,
12/21/1976
|
10 |
61 |
HLNC-15,
12/22/1976
|
|
HIG series,
1977-1978 [subseries]:
|
10 |
62 |
HIG-1,
11/28/1977
|
10 |
63 |
HIG-2,
11/28/1977
|
10 |
64 |
HIG-3,
12/2/1977
|
10 |
65 |
HIG-4,
5/11/1978
|
10 |
66 |
HIG-5,
5/31/1978
|
10 |
67 |
HIG-NS-1,
1/11/1978
|
10 |
68 |
HIG-saline-2,
2/7/1978
|
10 |
69 |
HIG-saline-9,
7/12/1978
|
11 |
1 |
Nacl-01,
6/22/1978
|
11 |
2 |
Nacl-03,
7/10/1978
|
11 |
3 |
Nacl-04,
7/11/1978
|
11 |
4 |
Nacl-05,
7/12/1978
|
11 |
5 |
Nacl-3,
2/13/1978
|
11 |
6 |
Nacl-4,
2/22/1978
|
11 |
7 |
Nacl-5,
4/4/1978
|
11 |
8 |
Nacl-6,
4/18/1978
|
11 |
9 |
Nacl-7,
5/3/1978
|
11 |
10 |
Nacl-8,
5/10/1978
|
|
Hyperglycemia (LC) series,
1980-1987 [subseries]:
|
11 |
11 |
LC -- hyperglycemia 1,
1/15/1980
|
11 |
12 |
LC -- hyperglycemia 2,
1/28/1980
|
11 |
13 |
LC -- hyperglycemia 3,
2/1/1980
|
11 |
14 |
LC -- hyperglycemia 4,
12/3/980
|
11 |
15 |
LC -- hyperglycemia 5 -- Franz, Francesco, Jane, Esther, Sumio,
2/6/1980
|
11 |
16 |
LC -- hyperglycemia 6,
2/20/1980
|
11 |
17 |
LC -- hyperglycemia 7 -- Franz, Francesco, Jane, Esther, Sumio,
3/3/1980
|
11 |
18 |
LC -- hyperglycemia 8 -- Franz, Francesco, Sumio, Dr. Kennedy, Wolfgang, Jane Jehle, Esther,
3/12/1980
|
11 |
19 |
LC -- hyperglyc. 9 -- Franz, Francesco, Sumio, Jane, Dr. Kennedy, Wolfgang, Esther,
3/18/1980
|
11 |
20 |
LC -- hyperglycemia 10 -- Franz, Francesco, Sumio, Esther, Wolfgang, Dr. Kennedy,
3/27/1980
|
11 |
21 |
LC -- hyperglycemia 11 -- Franz, Francesco, Sumio, Dr. Kennedy, Wolfgang, Jane,
3/31/1980
|
11 |
22 |
LC -- hyperglycemia 12 -- Franz, Francesco, Sumio, Jane Jehle, Esther,
4/22/1980
|
11 |
23 |
LC -- hyperglycemia 13 -- Franz, Francesco, Sumio, Jane, Esther,
4/29/1980
|
11 |
24 |
LC -- hyperglycemia 14 -- Franz, Francesco, Sumio, Jane, Esther,
5/6/1980
|
11 |
25 |
LC -- hyperglycemia 15 -- Franz, Francesco, Sumio, Jane, Esther,
5/8/1980
|
11 |
26 |
LC -- hyperglycemia 16 -- Franz, Francesco, Jane, Esther,
5/13/1980
|
11 |
27 |
LC -- hyperglycemia 17 -- Franz, Francesco, Sumio, Jane, Esther,
5/19/1980
|
11 |
28 |
LC -- hyperglycemia 18 -- Franz, Francesco, Sumio, Jane,
5/21/1980
|
11 |
29 |
LC -- hyperglycemia 19 -- Franz, Francesco, Sumio, Jane, Esther,
5/23/1980
|
11 |
30 |
LC -- hyperglycemia 20 -- Franz, Francesco, Jane, Sumio, Esther,
5/30/1980
|
11 |
31 |
LC -- hyperglycemia 21 -- Franz, Francesco, Jane, Sumio,
5/30/1980
|
11 |
32 |
LC -- hyperglycemia 22 -- Franz, Francesco, Jane,
6/9/1980
|
11 |
33 |
LC -- hyperglycemia 23 -- Franz, Francesco, Jane,
6/11/1980
|
11 |
34 |
LC -- hyperglycemia 24 -- Franz, Francesco, Jane,
6/16/1980
|
11 |
35 |
LC -- hyperglycemia 25 -- Franz, Francesco, Jane,
6/19/1980
|
11 |
36 |
LC -- hyperglycemia 26 -- Franz, Francesco, Jane,
6/25/980
|
11 |
37 |
LC -- hyperglycemia 27 -- Franz, Francesco, Jane, Esther,
7/1/1980
|
11 |
38 |
LC -- hyperglycemia 28 -- Franz, Francesco, Sumio, Jane, Esther,
7/8/1980
|
11 |
39 |
LC -- hyperglycemia 29 -- Franz, Francesco, Jane, Esther,
7/10/1980
|
11 |
40 |
LC -- hyperglycemia 30 -- Franz, Francesco, Jane, Esther,
7/17/1980
|
11 |
41 |
LC -- hyperglycemia 31 -- Franz, Francesco, Jane, Esther,
7/21/1980
|
11 |
42 |
LC -- hyperglycemia 32 -- Franz, Francesco, Jane, Sumio, Esther,
7/24/1980
|
11 |
43 |
LC- hyperglycemia -- compiled data,
1980-1987
|
11 |
44 |
LC -- hyperglycemia -- error analyses, counting procedures, etc.,
1980
|
11 |
45 |
LC table -- species,
undated
|
|
Iodoantipyrine (IOD) series,
1976-1977 [subseries]:
|
11 |
46 |
Iodoantipyrine [ ]-CBF control 1,
4/1/1976
|
11 |
47 |
Iodoantipyrine [ ]-CBF control 2,
4/2/1976
|
11 |
48 |
Iodoantipyrine [ ]-CBF control 3,
4/3/1976
|
11 |
49 |
14c -- iodoantiyprine, [ ]-CBF control 4,
4/6/1976
|
11 |
50 |
14c -- iodoantipyrine, [ ]-CBF control 5,
4/6/1976
|
11 |
51 |
14c -- iodoantipyrine -- [ ]-CBF control 6,
4/7/1976
|
11 |
52 |
Chromatography for 14c -- iodoantipyrine,
7/7/1976
|
11 |
53 |
Chromatography of iodoantipyrin experiment -- by J. D. Brown,
1976
|
11 |
54 |
Dissolve of 14c -- iodoantipyrine into dioxane phosphov.,
undated
|
11 |
55 |
IOD-C-7, 14c iodoantiyprine normal cat,
8/19/1976
|
11 |
56 |
IOD-C-8,
1/6/1977
|
11 |
57 |
Iodoantipyrine cat normal control 1,
5/6/1976
|
11 |
58 |
Iodoantipyrine cat normal control 2,
5/14/1976
|
11 |
59 |
Iodoantipyrine normal CBF cat 3,
5/20/1976
|
11 |
60 |
Iodoantipyrine normal control 4,
5/27/1976
|
11 |
61 |
Iodoantipyrine cat normal control 5,
6/4/1976
|
11 |
62 |
Iodoantipyrine cat normal control 6,
6/11/1976
|
11 |
63 |
Iodoantipyrine cat study summary,
undated
|
11 |
64 |
Iodoantipyrine solubility property,
undated
|
11 |
65 |
Iodoantipyrine study summary,
undated
|
11 |
66 |
Iodoantipyrine, radiochromatogram -- CFG 1265,
1976
|
11 |
67 |
Iodoantipyrine, radiochromatogram -- CFQ 1460,
1976
|
|
IP series,
1993 [subseries]:
|
11 |
68 |
IPBF 1-4,
1993
|
11 |
69 |
IPBF 5-8,
1993
|
11 |
70 |
IPBF 9-12,
1993
|
11 |
71 |
IPBF 13-16,
1993
|
11 |
72 |
IPBF 17-20,
1993
|
12 |
1 |
IPBF 21-24,
1993
|
12 |
2 |
IPBF 25-28,
1994
|
12 |
3 |
IPBF 29-32,
1994
|
12 |
4 |
IPDG 2 L-NAME,
1993
|
12 |
5 |
IPDG 3 L-NAME,
1993
|
12 |
6 |
IPDG 4 saline,
1993
|
12 |
7 |
IPDG 5, saline,
1993
|
12 |
8 |
IPDG 6, L-NAME,
1993
|
12 |
9 |
IPDG 7, L-NAME,
1993
|
12 |
10 |
IPDG 8, saline,
1993
|
12 |
11 |
IPDG 9, saline,
1993
|
12 |
12 |
IPDG 10, L-NAME,
1993
|
12 |
13 |
IPDG 11, saline,
1993
|
12 |
14 |
IPDG 12, saline,
1993
|
12 |
15 |
IPDG 13, L-NAME,
1993
|
12 |
16 |
IPDG 14, saline,
1993
|
12 |
17 |
IPDG 15, saline,
1993
|
12 |
18 |
IPDG 16, L-NAME,
1993
|
12 |
19 |
IPDG 17, saline,
1993
|
12 |
20 |
IPDG 18, saline,
1993
|
|
KSA series,
1975-1976 [subseries]:
|
12 |
21 |
Antipyrine chromatography, KSA 101 and 102 (plasma),
1975
|
12 |
22 |
Series KSA-0: antipyrine for BDBF pulse inf. for laplace transf.,
undated
|
12 |
23 |
KSA-101, CBF (K-s) antipyrine, sq. wave 60',
1975
|
12 |
24 |
KSA-102, CBF (K-S) antipyrine, sq. wave 35',
1975
|
12 |
25 |
KSA-103, CBF (K-S) antipyrine, pulse-50 uc-60',
1975
|
12 |
26 |
KSA-103: chromatography on plasma and brain,
1976
|
12 |
27 |
KSA-104 and 105, in brain and plasma,
1976
|
12 |
28 |
KSA-104, discarded,
1976
|
12 |
29 |
KSA-105, discarded,
1976
|
12 |
30 |
KSA-106, discarded,
1976
|
12 |
31 |
KSA-107, discarded,
1976
|
12 |
32 |
KSA-108, discarded,
undated
|
12 |
33 |
KSA-109, discarded,
1976
|
12 |
34 |
KSA-110, discarded,
1976
|
12 |
35 |
KSA-114, discarded,
1976
|
12 |
35 |
KSA-118, discarded,
1976
|
12 |
37 |
KSA-119, discarded,
1976
|
12 |
38 |
KSA-120, discarded,
1976
|
12 |
39 |
KSA-124,
undated
|
12 |
40 |
KSA-127, discarded,
1976
|
12 |
41 |
KSA-128, discarded,
1977
|
12 |
42 |
KSA-129, normal control (immobilization),
1977
|
12 |
43 |
KSA-131, 5% CO2, CBF,
1977
|
12 |
44 |
KSA-132, normal control,
1977
|
12 |
45 |
KSM-101, methylglucose as tracer for GCBF,
1975
|
12 |
46 |
KSM-102, methylglucose as tracer for GCBF,
1975
|
12 |
47 |
Series KSH: hippuric acid as tracer for GCBF,
1976
|
12 |
48 |
Series KSM1 -- KSM3: methylglucose as tracer for GCBF,
1975
|
|
Lidocaine (Lido) series,
1978-1979 [subseries]:
|
12 |
49 |
Lido-1, control,
7/24/1978
|
12 |
50 |
Lido-1',
7/24/1978
|
12 |
51 |
Lido-2,
8/3/1978
|
12 |
52 |
Lido-3, 2 lidocaine,
8/10/1978
|
12 |
53 |
Lido-4, 1 lidocaine,
8/10/1978
|
12 |
54 |
Lido-5, saline control,
1/11/1979
|
12 |
55 |
Lido-5', no seizure history,
1/11/1979
|
12 |
56 |
Lido-6, saline,
1/12/1979
|
12 |
57 |
Lido-6', lidocaine,
1/12/1979
|
12 |
58 |
Lido-7, saline,
1/19/1979
|
12 |
59 |
Lido-7', lidocaine,
1/19/1979
|
12 |
60 |
Lido-8, saline,
1/25/1979
|
12 |
61 |
Lido-8', lidocaine,
1/25/1979
|
12 |
62 |
Lido-9, saline,
1/26/1979
|
12 |
63 |
Lido-9' (experimental animal),
1/26/1979
|
12 |
64 |
Lido-10, saline control,
2/1/1979
|
12 |
65 |
Lido-10', lidocaine,
2/1/1979
|
12 |
66 |
Lido-11, saline control,
2/2/1979
|
12 |
67 |
Lido-11', lidocaine,
2/2/1979
|
12 |
68 |
Lido-12, saline,
2/15/1979
|
12 |
69 |
Lido-12', lidocaine,
2/15/1979
|
12 |
70 |
Lido-13, saline,
2/16/1979
|
12 |
71 |
Lido-13', lidocaine,
2/16/1979
|
12 |
72 |
Lidocaine summary,
1979
|
|
Glucose Utilization (LCGU) series,
1977-1987 [subseries]:
|
12 |
73 |
Cerebral structure w/ signif. changes in LCGU at higher doses of D-LSD,
1976-1977
|
12 |
74 |
Effects of LSD on LCGU in individual structures as a function of dose,
undated
|
12 |
75 |
Experiments -- hyperglycemia R.C. average,
1984
|
12 |
76 |
Free moving immobilization on LCGU and LCBF,
1978
|
12 |
77 |
Glucose / LCGU : from 0' -- 120',
undated
|
12 |
78 |
Hyperglycemia LCGU experiments -- excluded and misc.,
1980-1982
|
13 |
1 |
Hyperglycemia LCGU experiments -- excluded and misc. [cont'd.],
1980-1982
|
13 |
2 |
Hyperglycemia LCGU experiments -- used and tables,
1982
|
13 |
3 |
Hyperglycemia LCGU experiments 450,
1984
|
13 |
4 |
Hyperglycemia LCGU experiments 450 (programming changes),
1984
|
13 |
5 |
Hyperglycemia LCGU experiments 550A,
1984
|
13 |
6 |
Hyperglycemia, 2DG, 450's,
1984
|
13 |
7 |
L.C.G.U. (pulse exp.) parameters: new 3 rate constants,
1986
|
13 |
8 |
L.C.G.U. (pulse experiments) from Dr. Shinohara's data representative structures,
1977
|
13 |
9 |
LCGU -- pulse experiments -- LC=0.483 -- parameters: new 3 rate constants,
1986
|
13 |
10 |
LCGU -- sandro,
undated
|
13 |
11 |
LCGU -- taro,
undated
|
13 |
12 |
LCGU (pulse experiments) -- 5 rate constants (K4*=0.002),
1986
|
13 |
13 |
LCGU (pulse experiments) Shinohara series -- graphs -- representative structures,
1977
|
13 |
14 |
LCGU (pulse) parameters 5 rate constants (K4*=0.0014),
1986
|
13 |
15 |
LCGU (square exp.) parameters 5 rate constants (K4*=0.001),
1986
|
13 |
16 |
LCGU (square wave experiments) graphs,
undated
|
13 |
17 |
LCGU (square wave experiments) gray structures,
undated
|
13 |
18 |
LCGU (square wave experiments) white structures,
undated
|
13 |
19 |
LCGU hyperglycemia experiments -- Franz, Francesco,
1980
|
13 |
20 |
LCGU pulse experiments -- 5 rate constants (K4*=0.001),
1986
|
13 |
21-23 |
Local Cerebral Glucose Utilization,
1987
|
13 |
24 |
Shinohara pulse data -- LCGU w/5 -- H model -- K4=.002, K5=.05,
1986
|
13 |
25 |
Spinal cord (sleep) -- LCGU,
undated
|
13 |
26 |
Summary of LCGU (pulse) with original rate constants,
1987
|
13 |
27 |
Summary of local LCGU -- square wave exp.,
undated
|
13 |
28 |
Table for LCGU value,
undated
|
13 |
29 |
The effect of NMA on LCGU in the rat,
undated
|
13 |
30 |
Weighted average LCGU -- pulse experiments,
undated
|
|
LS series,
1977-1979 [subseries]:
|
14 |
1 |
LS-11, general,
8/29/1978
|
14 |
2 |
LS-II-1,
1977
|
14 |
3 |
LS-II-2,
11/8/1977
|
14 |
4 |
LS-II-3,
11/8/1977
|
14 |
5 |
LS-II-4,
11/8/1977
|
14 |
6 |
LS-II-5,
11/10/1977
|
14 |
7 |
LS-II-6,
11/11/1977
|
14 |
8 |
LS-II-7,
11/11/1977
|
14 |
9 |
LS-II-8,
12/9/1977
|
14 |
10 |
LS-II-9,
12/9/1977
|
14 |
11 |
LS-II-10,
12/9/1977
|
14 |
12 |
LS-II-11,12,13,
2/24/1978
|
14 |
13 |
LS-II-14,15,16,
4/3/1978
|
14 |
14 |
LS-II-17,
4/7/1978
|
14 |
15 |
LSB-2,
1979
|
14 |
16 |
LSB-3,
1977
|
14 |
17 |
LSB-4,
1977
|
14 |
18 |
LSB-5,
1977
|
14 |
19 |
LSB6-10,
1977
|
|
MG series,
1973, 1988-1989 [subseries]:
|
14 |
20 |
Extracting rat brain containing 3H-MG with hexane and chloroform by H. Nakanishi,
1988-1989
|
14 |
21 |
HIGH std.-2, 14c-MG,
10/2/1978
|
14 |
22 |
HIGH-STD-3, 14c-MG,
10/2/1978
|
14 |
23 |
MG and hypothalam atlas [computer disk],
undated
|
14 |
24 |
MG series '73,
1973
|
14 |
25 |
MG-1, 5' cont.,
1973
|
14 |
26 |
MG-2, 10' -- cont.,
1973
|
14 |
27 |
MG-3, 20' -- cont.,
1973
|
14 |
28 |
MG-4, 30' -- cont.,
1973
|
14 |
29 |
MG-5 (C14), 2 hrs.,
1973
|
14 |
30 |
MG-6 (C14), 1 min.,
1973
|
14 |
31 |
MG 7 (C14), 15' cont.,
1973
|
14 |
32 |
MG-8 (C14), 60' cont.,
1973
|
14 |
33 |
MG-9, 45' cont.,
1973
|
14 |
34 |
MG-10 (C14), 4' -- cont.,
1973
|
14 |
35 |
MG-11 (C14), 45' -- cont.,
1973
|
14 |
36 |
MG-12 (C14), 40' -- bol. C.S.F.,
1973
|
14 |
37 |
MG-13 (C14), 4' -- cont.,
1973
|
14 |
38 |
MG-14 (C14), 50' -- bol. C.S.F.,
1973
|
14 |
39 |
MG-15, 75' -- bol. C.S.F.,
1973
|
14 |
40 |
MG-16, 120' -- bol. C.S.F.,
1973
|
14 |
41 |
MG-17, 60' -- bol. C.S.F.,
1973
|
14 |
42 |
MG-18, 240' -- bol. C.S.F.,
1973
|
14 |
43 |
MG-101 and 102, 30' -- B -- 51 u.,
1973
|
14 |
44 |
MG-103 and 104, 45' -- B -- 76 uc.,
1973
|
14 |
45 |
MG-105, B -- 120' -- 51 uc.,
1973
|
14 |
46 |
MG-106 and 107, B -- 45' -- 51 uc.,
1973
|
14 |
47 |
MG-108, B -- 120' -- 51 uc.,
1973
|
14 |
48 |
MG-109 and 110, B -- 60 -- 51 uc.,
1973
|
14 |
49 |
MG-111 and 112, B -- 75' -- 51 uc.,
1973
|
14 |
50 |
MG-113 and 114, B -- 90' -- 51 uc.,
1973
|
|
MSG series,
1978 [subseries]:
|
14 |
51 |
MSG-01,
6/22/1978
|
14 |
52 |
MSG-03,
7/10/1978
|
14 |
53 |
MSG-04,
7/11/1978
|
14 |
54 |
MSG-05,
7/11/1978
|
14 |
55 |
MSG-06,
7/12/1978
|
14 |
56 |
MSG-07 (experiment stop),
7/12/1978
|
14 |
57 |
MSG-1,
1/11/1978
|
14 |
58 |
MSG-2,
2/7/1978
|
14 |
59 |
MSG-3,
2/13/1978
|
14 |
60 |
MSG-4,
2/25/1978
|
14 |
61 |
MSG-5,
4/4/1978
|
14 |
62 |
MSG-6,
4/18/1978
|
14 |
63 |
MSG-7,
5/3/1978
|
|
Radioactive isotope studies
[subseries]:
|
152 |
7 |
Correspondence - miscellaneous,
[1951-1952]
|
152 |
8 |
Radioactivity work,
[c.1950]
|
152 |
9 |
Phosphorous 32,
[c.1952]
|
152 |
10 |
Radioactive iodine - I131,
[c.1952]
|
152 |
11 |
Radioactive Krypton,
[1951]
|
152 |
12 |
Krypton study,
[1952]
|
152 |
13 |
[Investigation of effectiveness of circulation and radioactive isotope tracers],
[c.1950s]
|
|
Na24 series,
1956-1957 [subseries]:
|
152 |
14 |
[Radioactive Sodium [Na24] USPHS study],
[1951-1953]
|
152 |
15 |
Na24 clearance with perfusion in dogs with blood flow determinations,
[1953]
|
14 |
64 |
[patient name redacted] -- LBF -- Na24,
1956
|
14 |
65 |
[patient name redacted] -- LBF -- Na24,
1956
|
14 |
66 |
[patient name redacted] -- LBF -- Na24,
1957
|
14 |
67 |
[patient name redacted] -- LBF -- Na24,
1956
|
14 |
68 |
[patient name redacted] -- LBF -- Na24,
1956
|
14 |
69 |
[patient name redacted] -- LBF -- Na24,
1956
|
14 |
70 |
[patient name redacted] -- LBF -- Na24,
1957
|
14 |
71 |
[patient name redacted] -- LBF -- Na24,
1956
|
14 |
72 |
[patient name redacted],
1957
|
14 |
73 |
[patient name redacted] -- LBF -- Na24,
1957
|
14 |
74 |
[patient name redacted] -- LBF -- Na24,
1957
|
14 |
75 |
[patient name redacted] -- LBF -- Na24,
1956
|
14 |
76 |
[patient name redacted] -- LBF -- Na24,
1956
|
14 |
77 |
[patient name redacted] -- LBF -- Na24,
1957
|
14 |
78 |
NA24,
1954
|
14 |
79 |
Na24 -- leg blood flow studies,
1956
|
14 |
80 |
Na24 -- leg blood flow studies -- book 2,
1957
|
14 |
81 |
[patient name redacted] -- LBF -- Na24,
1957
|
14 |
82 |
[patient name redacted] -- LBF -- Na24,
1957
|
14 |
83 |
[patient name redacted] -- LBF -- Na24,
1957
|
14 |
84 |
[patient name redacted] -- LBF -- Na24,
1956
|
14 |
85 |
[patient name redacted] -- LBF -- Na24,
1956
|
14 |
86 |
[patient name redacted] -- LBF -- Na24,
1956
|
14 |
87 |
[patient name redacted] -- LBF -- Na24,
1956
|
14 |
88 |
[patient name redacted] -- LBF -- Na24,
1956
|
|
Rolled paper graph readouts
|
134 |
|
[patient name redacted], muscular dystrophy, control and exercised,
1/24/1957 [RESTRICTED PHI]
|
134 |
|
[patient name redacted],
6/9/1957 [RESTRICTED PHI]
|
134 |
|
[patient name redacted], LBF,
5/15/1957 [RESTRICTED PHI]
|
134 |
|
[patient name redacted], muscular dystrophy, control and exercised,
11/1/1956 [RESTRICTED PHI]
|
134 |
|
[patient name redacted], myotonia atrophy, LBF with exercise,
5/16/1957 [RESTRICTED PHI]
|
134 |
|
[patient name redacted],
10/10/1956 [RESTRICTED PHI]
|
134 |
|
[patient name redacted], normal control, control priscoline,
3/7/1957 [RESTRICTED PHI]
|
134 |
|
[patient name redacted], LBF, muscular dystrophy with exercise,
1/20/1957 [RESTRICTED PHI]
|
134 |
|
[patient name redacted], leg blood flow,
10/11/1956 [RESTRICTED PHI]
|
134 |
|
[patient name redacted], leg blood flow,
10/31/1956 [RESTRICTED PHI]
|
134 |
|
[patient name redacted], leg blood flow,
2/21/1957 [RESTRICTED PHI]
|
134 |
|
[patient name redacted], normal, control Arlidin,
3/21/1957 [RESTRICTED PHI]
|
134 |
|
[patient name redacted], normal control-LBF, Na24 with Arlidin,
2/1957 [RESTRICTED PHI]
|
134 |
|
[patient name redacted], LBF -- normal control, with priscoline, 1, 4, leg counts, Na24,
5/14/1957 [RESTRICTED PHI]
|
134 |
|
[patient name redacted], normal control -- LBF with Na24, Priscoline, 50mg, I.A.,
12/12/1956 [RESTRICTED PHI]
|
134 |
|
[patient name redacted], muscular dystrophy, 1-control, 2-exercise,
1/23/1957 [RESTRICTED PHI]
|
134 |
|
[patient name redacted], LBF leg counts, Na24, normal control, with Arlidin, 10mg. I.A.,
10/11/1956 [RESTRICTED PHI]
|
134 |
|
[patient name redacted], LBF with Na24, normal control with priscoline, 50mg, I.A.,
3/7/1957 [RESTRICTED PHI]
|
134 |
|
[patient name redacted], leg blood flow, muscular dystropy, control and exercise,
11/1/1956 [RESTRICTED PHI]
|
134 |
|
[patient name redacted], leg counts of Na24 at 100 [cm],
10/10/1956 [RESTRICTED PHI]
|
134 |
|
[patient name redacted], Arlidin,
3/21/1957 [RESTRICTED PHI]
|
134 |
|
[patient name redacted], myotonia dystrophica, Na24 leg blood flow with exercise,
5/16/1957 [RESTRICTED PHI]
|
135 |
|
[patient name redacted] (paranoid schizophrenia), leg blood flow control and exercise,
12/13/1957 [RESTRICTED PHI]
|
135 |
|
[patient name redacted], muscular dystrophy with exercise, Na24, leg blood flow,
2/20/1957 [RESTRICTED PHI]
|
135 |
|
[patient name redacted], LBF with Na24,
undated [RESTRICTED PHI]
|
135 |
|
[patient name redacted], muscular dystrophy with exercise, Na24 leg blood flow,
1/24/1957 [RESTRICTED PHI]
|
135 |
|
[patient name redacted], muscular dystrophy, LBF, Na24 with exercise,
1/24/1957 [RESTRICTED PHI]
|
135 |
|
[patient name redacted], muscular dystrophy, LBF with Na24, exercise,
9/20/1956 [RESTRICTED PHI]
|
135 |
|
[patient name redacted], normal control, Arlidin, 10 mg, I.A.,
6/19/1957 [RESTRICTED PHI]
|
135 |
|
[patient name redacted], s, LBF with Na24, Arlidin, 10 mg. I.A.,
10/31/1956 [RESTRICTED PHI]
|
135 |
|
[patient name redacted],
12/12/1956 [RESTRICTED PHI]
|
135 |
|
[patient name redacted], leg blood flow, 1-control, 2-Arlidin,
10/31/1956 [RESTRICTED PHI]
|
135 |
|
[patient name redacted],
6/21/1956 [RESTRICTED PHI]
|
135 |
|
[patient name redacted], LBF, Na24 with exercise, schizo.,
12/13/21956 [RESTRICTED PHI]
|
135 |
|
[patient name redacted], LBF with Na24,
7/11/1956 [RESTRICTED PHI]
|
135 |
|
[patient name redacted], myotonia dystrophica, LBF with Na24, exercise,
5/16/1957 [RESTRICTED PHI]
|
135 |
|
[patient name redacted], LBF with Na24, normal control, with Arlidin, 10 mg, I.A.,
10/11/1956 [RESTRICTED PHI]
|
135 |
|
[patient name redacted], LBF with Na24, dystrophy, with exercise,
11/1/1956 [RESTRICTED PHI]
|
135 |
|
[patient name redacted], LBF with Na24, normal control, Arlidin, 10 mg, I.A.,
3/21/1957 [RESTRICTED PHI]
|
135 |
|
[patient name redacted], LBF with Na24, normal control with Priscoline, 50 mg, I.A.,
12/12/1956 [RESTRICTED PHI]
|
135 |
|
[patient name redacted], normal control, leg blood flow -- Na24, Arlidin, 10 mg, I.A.,
2/21/1957 [RESTRICTED PHI]
|
135 |
|
[patient name redacted], LBF with Na24, Priscoline, I.A.,
9/19/1956 [RESTRICTED PHI]
|
135 |
|
[patient name redacted], normal control, LBF with Na24, Arlidin, 10 mg, I.A.,
6/19/1957 [RESTRICTED PHI]
|
135 |
|
[patient name redacted], LBF with Na24, normal control, Priscoline, 50 mg., I.A.,
3/7/1957 [RESTRICTED PHI]
|
135 |
|
[patient name redacted], dystrophy, LBF with Na24 and exercise,
2/20/1957 [RESTRICTED PHI]
|
135 |
|
[patient name redacted], LBF with Na24 and exercise,
10/10/1956 [RESTRICTED PHI]
|
135 |
|
[patient name redacted], LBF with Na24,
6/6/1956 [RESTRICTED PHI]
|
135 |
|
[patient name redacted],
7/12/1956 [RESTRICTED PHI]
|
135 |
|
[patient name redacted], LBF with Na24, normal control, Priscoline, 50 mg., I.A.,
8/1/1956 [RESTRICTED PHI]
|
135 |
|
[patient name redacted], muscular dystrophy with exercise,
1/23/1957 [RESTRICTED PHI]
|
135 |
|
[patient name redacted], muscular dystrophy, LBF with Na24,
1/23/1957 [RESTRICTED PHI]
|
|
Lab notebooks
|
154 |
1-6 |
Books 1-6,
1952-1953 [RESTRICTED PHI]
|
153 |
1-4 |
Na24 clearance perfusion, book 1-2 [dogs],
1952-1953
|
|
New born monkey (NBM) series,
1970-1979, 1983-1989 [subseries]:
|
14 |
89 |
Assay of monkey blood,
1978
|
14 |
90 |
LCM 6,
9/30/1976
|
14 |
91 |
LCM-7,
10/14/1976
|
14 |
92 |
LCM 9,
11/18/1976
|
14 |
93 |
Monkey K-732-1,
1971
|
14 |
94 |
Monkey K739-2,
1971
|
14 |
95 |
Monkey lumped constant study, no. 1 [photograph],
1976
|
14 |
96 |
Monkey lumped constant study, no. 2,
1976
|
14 |
97 |
Monkey lumped constant study, no 3,
1976
|
14 |
98 |
Monkey lumped constant study, no 4,
1976
|
14 |
99 |
Monkey lumped constant study, no. 5,
1976
|
14 |
100 |
Monkey-control -- misc.,
1985-1989
|
14 |
101 |
NBM-101, tarsoraphy at. 2 days,
1976-1985
|
14 |
102 |
NBM-2, rt. eye patched (LCGU),
11/24/1978
|
14 |
103 |
NBM-3, LCGU 3,
1976-1977
|
14 |
104 |
NBM-4 [diskette],
1983
|
14 |
105 |
NBM4, new born monkey, LCGU-control,
1976
|
14 |
106 |
NBM-5 (LCGU control),
3/15/1976
|
15 |
1 |
NBM-6, LCGU,
3/22/1976
|
15 |
2 |
NBM7 (new born monkey control),
1976
|
15 |
3 |
NBM-8, LCGU-30', r. eye patched,
1978
|
15 |
4 |
Newborn monkey, LCGU control (NBM1),
1976
|
15 |
5 |
PEN. SEIZ.: adult monk. controls + experimentals,
1970
|
15 |
6 |
PEN. SEIZ.: newborn monk. experimentals,
1970
|
15 |
7 |
PEN. SEIZ: newborn monkeys controls,
1970
|
15 |
8 |
Pen-C, 1,
1975
|
15 |
9 |
Series S.M.: laplace transform, 2-DG conscious monkeys,
1976
|
15 |
10 |
Statist. -- new born monkey,
1979
|
15 |
11 |
Stimulated monkey -- summary tables and graphs,
undated
|
|
PCP series,
1986-1987 [subseries]:
|
15 |
12 |
PCP-1 -- 10 mg/kg,
1986
|
15 |
13 |
PCP -- 2 Saline 0.36,
1986
|
15 |
14 |
PCP -- 3 1 mg/kg,
1988
|
15 |
15 |
PCP -- 4 N. Saline,
1986
|
15 |
16 |
PCP -- 5 0.3/kg,
1986
|
15 |
17 |
PCP -- 6 3mg/kg,
1986
|
15 |
18 |
PCP -- 7 1mg/kg,
1987
|
15 |
19 |
PCP -- 8 0.1mg/kg,
1987
|
15 |
20 |
PCP -- 9 10mg/kg,
1987
|
15 |
21 |
PCP -- 10 N.S.,
1988
|
15 |
22 |
PCP -- 11 3mg/kg,
1986
|
15 |
23 |
PCP -- 12 0.3mg/kg,
1986
|
15 |
24 |
PCP -- 13 1mg/kg,
1987
|
15 |
25 |
PCP -- 14 0.1mg/kg,
1987
|
15 |
26 |
PCP -- 15 3.0mg/kg,
1987
|
15 |
27 |
PCP -- 16 N.S.,
1987
|
15 |
28 |
PCP -- 17 0.3mg/kg,
1986
|
15 |
29 |
PCP -- 18 10mg/kg,
1986
|
15 |
30 |
PCP -- 19 N.S.,
1986
|
15 |
31 |
PCP -- 20 0.1mg/kg,
1987
|
15 |
32 |
PCP -- 21 0.3/kg,
1987
|
15 |
33 |
PCP 21-2,
1987
|
15 |
34 |
PCP -- 22 3mg/kg,
1987
|
15 |
35 |
PCP -- 23 10mg/kg,
1987
|
15 |
36 |
PCP -- 24 N.S.,
1987
|
15 |
37 |
PCP -- 25 1mg/kg,
1986
|
15 |
38 |
PCP -- 26 10mg/kg,
1987
|
15 |
39 |
PCP 27 0.3mg/kg,
1987
|
15 |
40 |
PCP 28 0.1mg/kg,
1988
|
15 |
41 |
PCP Data,
1987
|
15 |
42 |
PCP Raw Data,
1986
|
|
PT series,
1949-1950, 1979-1987 [subseries]:
|
15 |
43 |
PT series -- scp*(t)/cp* -- scp*dt/T,
1949-1950
|
15 |
44 |
Pulse 2DG experiments -- PT series -- Ken Mori StCp*(t)dt,
1986
|
15 |
45 |
PT series plus experiments -- physiological conditions,
1987
|
15 |
46 |
Summary PT series -- stretch time etc., pulse exp. mori,
1979-1986
|
15 |
47 |
PT-2 -- 60 min.,
July 25, 1986
|
15 |
48 |
PT-6 -- 35 min.,
July 26, 1986
|
15 |
49 |
PT-7 -- 120 min.,
Aug. 4, 1986
|
15 |
50 |
PT-8 -- 60 min.,
Aug. 4, 1986
|
15 |
51 |
PT-9 -- 25 min.,
Aug. 4, 1986
|
15 |
52 |
PT-10 -- 90 min. exp.,
Aug. 5, 1986
|
15 |
53 |
PT-11 -- 35 min. exp.,
Aug. 5, 1986
|
15 |
54 |
PT-12 -- 45 min. exp.,
Aug. 5, 1986
|
15 |
55 |
PT-13 -- 120 min. exp.,
Aug. 1986
|
15 |
56 |
PT-14 -- 60 min.,
Aug. 6, 1986
|
15 |
57 |
PT-15 -- 25 min.,
Aug. 6, 1986
|
15 |
58 |
PT-16 -- 90 min. exp.,
Aug. 7, 1986
|
15 |
59 |
PT-17 -- 45 min. exp.,
Aug. 7, 1986
|
15 |
60 |
PT-18 -- 35 min. exp.,
Aug. 7, 1986
|
15 |
61 |
PT-20 -- 60 min. exp.,
Aug. 8, 1986
|
15 |
62 |
PT-21,
Aug. 8, 1986
|
15 |
63 |
PT 22 -- 120 min. exp.,
Aug. 11, 1986
|
15 |
64 |
PT 23 -- 90 min. exp.,
Aug. 11, 1986
|
15 |
65 |
PT 24 -- 4-5 min. exp.,
Aug. 11, 1986
|
15 |
66 |
PT-25 -- 120 min. exp.,
Aug. 13, 1986
|
15 |
67 |
PT-26 -- 90 min. exp.,
Aug. 13, 1986
|
15 |
68 |
PT-27 -- 35 m in. exp.,
Aug. 13, 1986
|
15 |
69 |
PT-28 -- 45 min. exp.,
Aug. 14, 1986
|
15 |
70 |
PT-29 -- 25 min. exp.,
Aug. 14, 1986
|
15 |
71 |
PT-31 -- 25 min.,
Nov. 17, 1986
|
15 |
72 |
PT-32 -- 90 min.,
Nov. 18, 1986
|
15 |
73 |
PT-33 -- 25 min.,
Nov. 18, 1986
|
15 |
74 |
PT-34- 45 min. exp.,
Nov. 24, 1986
|
15 |
75 |
PT-35 -- 35 min. exp.,
Nov. 24, 1986
|
15 |
76 |
PT-36 -- 35 min.,
Nov. 24, 1986
|
15 |
77 |
PT-37 -- 45 min.,
Nov. 25, 1986
|
15 |
78 |
PT-38 -- 35 min.,
Nov. 25, 1986
|
15 |
79 |
PT-39 -- 45 min. exp.,
Nov. 26, 1986
|
15 |
80 |
PT-40 -- 25 min. exp.,
Nov. 26, 1986
|
15 |
81 |
PT-41 -- 25 min. exp.,
Nov. 26, 1986
|
15 |
82 |
PT-42 -- 60 min. exp.,
Nov. 28, 1986
|
15 |
83 |
PT-43 -- 35 min. exp.,
Nov. 28, 1986
|
15 |
84 |
PT-44 -- 45 min. exp.,
Nov. 28, 1986
|
15 |
85 |
PT series -- parameters with new three rate constants -- K1*=0.232, K2*=0.240, K3*=0.061,
1985-1986
|
|
PX series,
1978 [subseries]:
|
15 |
86 |
PX-0 (.42 mg/kg),
5/3/1978
|
15 |
87 |
PX-01 (.42 mg/kg),
8/21/1978
|
15 |
88 |
PX-02 (.42 mg/kg),
8/21/1978
|
15 |
89 |
PX-1 (21 mg/kg, 8.6 mg pulse),
2/8/1978
|
15 |
90 |
PX-2 (7.8 mg pulse),
2/29/1978
|
15 |
91 |
PX-3 (8.5 mg pulse),
2/29/1978
|
15 |
92 |
PX-4 (21 mg/kg, 8.2 mg pulse),
3/15/1978
|
16 |
1 |
PX-5 (4.2 mg/kg),
3/30/1978
|
16 |
2 |
PX-6 (4.2 mg/kg),
3/30/1978
|
16 |
3 |
PX-7 (4.2 mg/kg),
4/5/1978
|
16 |
4 |
PX-8 (4.2 mg/kg),
4/12/1978
|
16 |
5 |
PX-9 (42 mg/kg),
4/12/1978
|
16 |
6 |
Px-10,
4/19/1978
|
16 |
7 |
Px-11,
4/19/1978
|
16 |
8 |
PX-12 (4.2 mg/kg),
4/27/1978
|
16 |
9 |
PX-13 (4.2 mg/kg),
5/9/1978
|
16 |
10 |
PX-14 (42 mg/kg),
5/9/1978
|
16 |
11 |
PX-15 (4.2 mg/kg),
8/21/1978
|
16 |
12 |
PX-16 (21 mg/kg),
8/21/1978
|
16 |
13 |
PX-17 (42 mg/kg),
8/25/1978
|
16 |
14 |
PX-18 (9 mg/kg),
12/10/1978
|
16 |
15 |
PX-19 (9 mg/kg),
12/10/1978
|
16 |
16 |
PX-20 (9 mg/kg),
12/11/1978
|
16 |
17 |
PX-21 (9 mg/kg),
12/22/1978
|
16 |
18 |
PX-22 (9 mg/kg),
12/13/1978
|
|
SM series,
1973-1985 [subseries]:
|
16 |
19 |
SM-1, B-45'-320 ul -- rt. eye covered and wurtz,
1975
|
16 |
20 |
Series SM-2: unilateral patching,
1973
|
16 |
21 |
SM-2A, B'-45'-100 uc, both eyes opened,
1973-1978
|
16 |
22 |
SM-3, P-45'-250 uc. (rt. eye patched),
1973-1975
|
16 |
23 |
SM-3A, visual: rt. eye removed, P-45'-250 uc,
1973-1975
|
16 |
24 |
SM-4A, both eyes opened and wurtz pattern -- P-45'-300 uc,
1973-1975
|
16 |
25 |
Series SM-5: both eyes patched,
1975
|
16 |
26 |
SM-6, 45'-300 mc -- both eyes patched,
1974-1975
|
16 |
27 |
Series SM-7: eyes intact + stimulation,
1974
|
16 |
28 |
SM-8A,
1974-1977
|
16 |
29 |
Series SM-9A: eyes intact + stimulation,
1975-1977
|
16 |
30 |
SM-10, both eyes intact and wurtz pattern,
1974-1975
|
16 |
31 |
SM-11,
1978
|
16 |
32 |
SM-11, both eyes intact and wurtz, pattern,
1974-1977
|
16 |
33 |
Series SM-12: eyes intact + stimulation,
1974-1977
|
16 |
34 |
SM-13, left eye removed and wurtz,
1974
|
16 |
35 |
SM-14, rt. eye removed and ambient light,
5/1/1975
|
16 |
36 |
Series SM-15: unilateral enucleation,
1975
|
16 |
37 |
Series SM-16: unilateral enucleation,
1975
|
16 |
38 |
SM-17, left eye patched and wurtz,
8/7/1975
|
16 |
39 |
Series SM-18: unilateral enucleation,
undated
|
16 |
40 |
SM-19, left eye patched and wurtz,
11/6/1975
|
16 |
41 |
SM-20, left eye patched and wurtz,
11/20/1975
|
16 |
42 |
SM-21, rt. eye patched and wurtz [photograph],
12/23/1975
|
16 |
43 |
SM-22, left eye removed and wurtz,
12/23/1975
|
16 |
44 |
SM-23, both eyes open,
1/23/1976
|
16 |
45 |
SM-24, both eyes patched,
2/5/1976
|
16 |
46 |
SM-25, 2/19 -- rt. eye patched and wurtz,
2/19/1976
|
16 |
47 |
SM-26, 3/19 -- rt. eye patched and wurtz,
3/19/1976
|
16 |
48 |
SM-27, 5/28 -- both eyes opened and wurtz,
5/28/1976
|
16 |
49 |
SM-28,
8/2/1976
|
16 |
50 |
SM-29,
11/4/1976
|
16 |
51 |
SM-30,
12/9/1976
|
17 |
1 |
SM-31,
1976-1985
|
17 |
2 |
SM-32,
1/18/1977
|
17 |
3 |
SM33 and SM24, densitometry,
undated
|
17 |
4 |
SM-33, both eyes occluded,
8/4/1977
|
17 |
5 |
SSM-1/SSM-3,
undated
|
17 |
6 |
SSM-2,
1979
|
17 |
7 |
SSM-2 [diskette],
4/7/1977
|
17 |
8 |
SSM-4 (rt. optic tract sectioned),
1977
|
17 |
9 |
SSM-4 [8 computer disk]",
1979
|
|
SR series,
1973-1974 [subseries]:
|
17 |
10 |
Series SR-1: visual alterations,
1973
|
17 |
11 |
Series SR-1A: visual alterations,
1973
|
17 |
12 |
Series SR-2: visual alterations,
1973
|
17 |
13 |
Series SR-2A: visual alterations,
1973
|
17 |
14 |
Series SR-3: visual alterations,
1973
|
17 |
15 |
Series SR-3A: visual alterations,
1973
|
17 |
16 |
SR-3B (l. eye remove),
1973
|
17 |
17 |
SR-4-I (r-eye remove),
1973
|
17 |
18 |
SR-4-II (l-eye remove),
1973
|
17 |
19 |
S.R.-5, (left eye patched, TOT -- darkness, I.P.S.),
1973
|
17 |
20 |
Series SSR: sciatic nerve stimulation,
1974
|
|
Thyroxine series,
1954-1975 [subseries]:
|
17 |
21 |
Reprints -- thyroxine,
1956
|
17 |
22 |
Summaries of thyroxine mitochondrial factor studies,
1964-1965
|
17 |
23 |
Summaries thyroxine effects on pyridine nucleotides,
1975
|
17 |
24 |
T4 effect on mitochondrial NAD+,
1970
|
17 |
25 |
Thyroxine -- illustrations [photographs, negatives],
undated
|
17 |
26 |
Thyroxine -- protein synthesis,
1955-1965
|
17 |
27 |
Thyroxine -- protein synthesis in vivo,
1963-1964
|
136 |
8-9 |
Thyroxine -- Protein Synthesis -- Index,
undated
|
17 |
28 |
Thyroxine -- uptake by brain,
1954-1955
|
17 |
29 |
Thyroxine analogues [photographs, negatives],
1963
|
17 |
30 |
Thyroxine effects on NAD+,
1974
|
17 |
31 |
Thyroxine effects on pyridine nucleotides -- amino-chance scans [folder 1 of 3],
1974-1975
|
17 |
32 |
Thyroxine effects on pyridine nucleotides -- amino-chance scans [folder 2 of 3],
1974-1975
|
17 |
33 |
Thyroxine effects on pyridine nucleotides -- amino-chance scans [folder 3 of 3],
1974-1975
|
17 |
34 |
Thyroxine effects on pyridine nucleotides,
1974
|
17 |
35 |
Thyroxine experiments,
1964
|
18 |
1 |
Thyroxine experiments -- book 2,
1957-1958
|
18 |
2 |
Thyroxine experiments -- book 3,
1958
|
18 |
3 |
Thyroxine factor [negatives],
undated
|
18 |
4 |
Thyroxine iodine studies,
1954-1955
|
18 |
5 |
Thyroxine mechanism -- tables and illus. [photographs, negatives],
undated
|
136 |
10 |
Thyroxine-Mitochondrial Factor -- Index [includes slides],
undated
|
18 |
6 |
Thyroxine project -- charts and slides [photographs, negatives],
undated
|
18 |
7 |
Thyroxine project -- charts and slides [photographs, negatives],
undated
|
18 |
8 |
Thyroxine solutions,
1959-1964
|
18 |
9 |
Thyroxine solutions II,
1965-1972
|
18 |
10-12 |
Thyroxine-mitochondrial factor -- preparations and properties -- book 1,
1966-1968
|
|
Whisker barrel (WB) series,
1991-1993 [subseries]:
|
18 |
13 |
WB i.v. study, statistics,
1992
|
18 |
14 |
01 whisker barrel series: control,
1991
|
18 |
15 |
WB-02 experiment NMA 30 mg/kg,
1991
|
18 |
16 |
WB-03 control,
1991
|
18 |
17 |
WB-04, control,
1991
|
18 |
18 |
WB-05, experiment NMA 30 mg/kg,
1991
|
18 |
19 |
WB-06, exp. normal saline 1.1 ml,
1991
|
18 |
20 |
WB-07, exp. NMA 30 mg/kg,
1991
|
18 |
21 |
WB-08, exp. NMA 30 mg/kg,
1991-1992
|
18 |
22 |
WB-09, control,
1991
|
18 |
23 |
WB-09, control,
1991
|
18 |
24 |
WB-11, exp. NMA 30 mg/kg,
1991
|
18 |
25 |
WB-12, NMA 100 mg/kg,
1991
|
18 |
26 |
WB-13, NMA 100 mg/kg,
1991
|
18 |
27 |
WB-14, NMA 100 mg/kg,
1991
|
18 |
28 |
WB-15, NMA 100 mg/kg i.v.,
1991
|
18 |
29 |
WB-16, control (saline + no stimulation),
1991
|
18 |
30 |
WB-17, NMA 30 mg/kg i.v.,
1991-1992
|
18 |
31 |
WB-18, control,
1991-1992
|
18 |
32 |
WB-19, saline i.v. + no stimulation,
1991
|
18 |
33 |
WB-20, control,
1991
|
18 |
34 |
WB-21, control,
1991-1992
|
18 |
35 |
WB-22, methyl ester,
1992
|
18 |
36 |
WB-22, methyl ester 30 mg/kg i.v.,
1992
|
18 |
37 |
WB-24, control,
1992
|
18 |
38 |
WB-25, NAME,
1992
|
18 |
39 |
WB-26, control (saline i.v. and no stimulation),
1992
|
18 |
40 |
WB-27, NAME,
1992
|
18 |
41 |
WB-28, control,
1992
|
18 |
42 |
WB-29, control,
1992
|
18 |
43 |
WB-30, nitro-L-arginine methylester,
1992
|
18 |
44 |
WB-31, control,
1992
|
18 |
45 |
WB-32, nitro-L-arginine methylester,
1992
|
18 |
46 |
WB-33, NAME,
1992
|
18 |
47 |
WB-34, control,
1992
|
18 |
48 |
WB-35, nitro-L-arginine methylester,
1992
|
18 |
49 |
WB-36, nitro, fast infusion,
1992
|
18 |
50 |
WB-37, control,
1992
|
18 |
51 |
WB-38, nitro-L-arginine M.E., 600 ug/rat,
1992
|
18 |
52 |
WB-39, control (DIR),
1992
|
18 |
53 |
WB-40, nitro (direct), 600 ug/rat,
1992
|
18 |
54 |
WB-41, control (direct),
1992
|
18 |
55 |
WB-42, nitro-L-arginine (direct),
1992
|
18 |
56 |
WB-43, nitro-L-arginine, 600 ug/rat,
1992
|
18 |
57 |
WB-44, control,
1992
|
18 |
58 |
WB-45, nitro-L-arginine, 600 ug/rat,
1992
|
18 |
59 |
WB-46, nitro-L-arginine, 600 ug/rat,
1992
|
18 |
60 |
WB-47, control,
1992
|
18 |
61 |
WB-48, control,
1992
|
18 |
62 |
WB-49, nitro-L-arginine, 600 ug/rat,
1992
|
18 |
63 |
WB-50, control,
1992
|
18 |
64 |
WB-51, nitro-L-arginine, 600 ug/rat,
1992
|
18 |
65 |
WB-52and53, 3H-nitro-L-arginine and intracisternal infusion,
1993
|
18 |
66 |
WB-54, chronic and NAME,
1993
|
18 |
67 |
WB-55, chronic i.p. and NAME,
1993
|
18 |
68 |
WB-56, chronic ad of NAME,
1993
|
18 |
69 |
WB-57, chronic i.p.,
1993
|
18 |
70 |
WB-58, chronic i.p.,
1993
|
18 |
71 |
WB-59, chronic i.p.,
1993
|
18 |
72 |
WB-60, L-NAME chronic i.p.,
1993
|
18 |
73 |
WB-61, chronic i.p.,
1993
|
18 |
74 |
WB-62, chronic i.p.,
1993
|
18 |
75 |
WB-63, saline chronic i.p.,
1993
|
18 |
76 |
WB-64, saline chronic i.p.,
1993
|
18 |
77 |
WB-65, saline chronic i.p.,
1993
|
18 |
78 |
WB-66, saline chronic i.p.,
1993
|
19 |
1 |
WB-cisternal infusion,
1992
|
19 |
2 |
WBDG -- DG parity check,
1992
|
19 |
3 |
WBDG-1,
1992
|
19 |
4 |
WBDG-2,
1991-1992
|
19 |
5 |
WBDG-3,
1991-1992
|
19 |
6 |
WBDG-4,
1992
|
19 |
7 |
WBDG-5,
1992
|
19 |
8 |
WBDG-6,
1992
|
19 |
9 |
WBDG-7,
1992
|
19 |
10 |
WBDG-8,
1992-1993
|
|
YOH series,
1978 [subseries]:
|
19 |
11 |
YOH-1 (.25 mg/kg/min.),
4/5/1978
|
19 |
12 |
YOH-3 (.25 mg/kg/min.),
7/10/1978
|
19 |
13 |
YOH-4 (.25 mg/kg/min.),
7/10/1978
|
19 |
14 |
YOH-5 (.1 mg/kg/min.),
7/11/1978
|
19 |
15 |
YOH-6 (.25 mg/kg/min.),
7/11/1978
|
19 |
16 |
YOH-7 (.1 mg/kg/min.),
7/11/1978
|
19 |
17 |
YOH-10 (.25 mg/kg/min.),
8/19/1978
|
19 |
18 |
YOH-11 (.1 mg/kg/min.),
8/30/1978
|
19 |
19 |
YOH-12 (.25 mg/kg/min.),
9/8/1978
|
19 |
20 |
YOH-13 (.25 mg/kg/min.),
9/8/1978
|
19 |
21 |
YOH-14 (.25 mg/kg/min.),
9/8/1978
|
19 |
22 |
YOH-15 (.025 mg/kg/min.),
9/18/1978
|
19 |
23 |
YOH-16 (.025 mg/kg/min.),
9/18/1978
|
19 |
24 |
YOH-17 (.1 mg/kg/min.),
12/14/1978
|
19 |
25 |
YOH-18 (.1 mg/kg/min.),
12/14/1978
|
19 |
26 |
YOH-19 (.05 mg/kg/min.),
12/15/1978
|
19 |
27 |
YOH-20 (.05 mg/kg/min.),
12/15/1978
|
19 |
28 |
YOH-21 (.05 mg/kg/min.),
12/18/1978
|
19 |
29 |
YOH-22 (.05 mg/kg/min.),
12/18/1978
|
19 |
30 |
YOH-23 (.05 mg/kg/min.),
12/19/1978
|
19 |
31 |
YOH-24 (.0025 mg/kg/min.),
12/20/1978
|
19 |
32 |
YOH-25 (.025 mg/kg/min.),
12/20/1978
|
19 |
33 |
YOH-26 (.025 mg/kg/min.),
12/20/1978
|
19 |
34 |
YOH-27 (.0025 mg/kg/min.),
12/21/1978
|
19 |
35 |
YOH-28 (.0025 mg/kg/min.),
12/21/1978
|
19 |
36 |
YOH-29 (.0025 mg/kg/min.),
12/21/1978
|
|
Other experiments,
1952-2003 [subseries]:
|
152 |
24 |
Laboratorie de Biochemie Generale at et Comparee de France, Paris -- experiment binder,
1968-1969
|
19 |
37 |
1. aging -- CBF -- Normal,
1955-1957
|
19 |
38 |
2. aging -- CBF -- hypertension,
1956
|
19 |
39 |
3. aging -- CBF -- arteriosclerosis,
1956-1957
|
19 |
40 |
4. aging -- CBF -- chronic brain syndrome,
1957-1958
|
19 |
41 |
B. aging -- patient material,
1957-1959
|
19 |
42 |
C. Aging -- Statistics,
1958-1959
|
19 |
43 |
C. Aging -- Statistics,
1959
|
19 |
44 |
D Aging -- Inter Correlations,
1959-1960
|
19 |
45 |
E Aging -- research data,
1959-1960
|
20 |
1 |
ANES series,
1993
|
20 |
2 |
ANES 1-5,
Jan. 5-11, 1993
|
20 |
3 |
ANES 6-10,
Jan. 12-25,1993
|
20 |
4 |
ANES 11-15,
Feb. 1-9, 1993
|
20 |
5 |
ANES 16-20,
Feb. 16-23, 1993
|
20 |
6 |
ANES 21-25,
March 21-31, 1993
|
20 |
7 |
ANES 26-30,
March 9-22, 1993
|
20 |
8 |
ANES 31-34,
March 23-28, 1993
|
20 |
9 |
ANES,
1992
|
20 |
10-11 |
Arterial curves -- O2 -- C02 series,
1956
|
20 |
12-13 |
Arterial curves -- SCL series [photographs],
1956
|
20 |
14 |
CE-1: lumped constant rat, 5%, CO2 inhal,
1974
|
20 |
15 |
CE-2: lumped constant rat, 5% CO2 inhal.,
undated
|
20 |
16 |
CE-3: lumped constant rat, 5% CO2 inhal.,
1975
|
20 |
17 |
CE-4: lumped constant rat, 5% CO2 inhal.,
1975
|
20 |
18 |
CK1, 60 min. normal control,
6/15/1978
|
20 |
19 |
CK2, 60 min.,
6/15/1978
|
20 |
20 |
CS-23,
7/10/1978
|
20 |
21 |
CS-24,
8/21/1978
|
20 |
22 |
CS-26,
12/13/1978
|
20 |
23 |
CS-27,
12/14/1978
|
20 |
24 |
G5 Ur W5 V4 original rate constants,
undated
|
20 |
25 |
Parameters (V4 V4 G6 W5) pulse experiments -- new 3 rate constants,
1985
|
20 |
26 |
HYP1 (10%),
1/15/1976
|
20 |
27 |
HYP2 (10%),
1/15/1976
|
20 |
28 |
HYP-3 (7.5% O2),
1/21/1976
|
20 |
29 |
HYP-4 (7.5% O2),
1/21/1976
|
20 |
30 |
Hypoxia 10% O2 behavior: observation,
1976
|
20 |
31 |
LCBF summary,
undated
|
20 |
32 |
LCBF summary for misc. data,
undated
|
20 |
33 |
Sheet for LCBF,
undated
|
20 |
34 |
1 washout constant exp., flow rate: 0.8 ml/min.,
1991
|
20 |
35 |
2 washout constant exp., flow rate: 1.0 ml/min.,
1991
|
20 |
36 |
03 washout constant exp., flow rate: 1.2 ml/min.,
1991
|
20 |
37 |
04 washout constant exp., flow rate: 0.6 ml/min.,
1991
|
20 |
38 |
05 washout constant exp., flow rate: 1.4 ml/min.,
1991
|
20 |
39 |
06 washout constant exp., flow rate: 1.6 ml/min.,
1991
|
20 |
40 |
Washout correction for LCBF equation,
undated
|
20 |
41-42 |
Wynn project -- alleged non-mitochondrial thyroxine stimulation of protein synthesis -- Nov. 9,
1970
|
20 |
43 |
2 Deoxyglucose Studies (Rat, Cat),
1973-1983
|
20 |
44 |
2.5 min.,
undated
|
20 |
45 |
5.0 min.,
undated
|
20 |
46 |
10 min.,
undated
|
20 |
47 |
15 min.,
undated
|
20 |
48 |
30 min.,
undated
|
20 |
49 |
45 min.,
undated
|
20 |
50 |
60 min.,
undated
|
20 |
51 |
90 min.,
undated
|
20 |
52 |
120 min.,
undated
|
20 |
53 |
14C Toluen internal std. -- lot 0060283A,
1986
|
20 |
54 |
14c-warfarin,
1993
|
20 |
55 |
Abrams -- lumped constant data,
1985
|
136 |
11 |
Absorption Spectra,
undated
|
20 |
56 |
Additional structure morphine,
undated
|
20 |
57 |
Alfred Benzon symposium,
1990
|
20 |
58 |
Amanda,
12/5/1979
|
20 |
59 |
Amersham standard calibration,
1978
|
20 |
60 |
Analytical ultracentrifuge records [photographs],
1966
|
20 |
61 |
Anesthesia record,
undated
|
21 |
1 |
Animal phosphate [photographs],
1978
|
21 |
2 |
AP vs. IAP rat summary,
undated
|
21 |
3 |
Arithmetic mean value of gray structures (pulse experiments),
1979
|
21 |
4 |
Arterial blood studies (Tbl 1) (from Reivitch, et. al.) [slides],
1977
|
21 |
5 |
Astroglial exp. -- amino acid analysis key,
1995
|
21 |
6 |
Astroglial exp. -- Dr. Kaufman's cell extract samples,
1995
|
21 |
7 |
Astroglial exp. -- intracellular A.A.,
1995
|
21 |
8 |
Atlas -- 1,
1980
|
21 |
9 |
Amino-acid-analyzen,
1992
|
21 |
10 |
A. V. blood curves -- desaturation curves studies,
1952-1956
|
21 |
11 |
Banzo (sleep control),
1980
|
21 |
12 |
Basil,
6/13/1979
|
21 |
13 |
Beckman polygraph calibration,
undated
|
21 |
14 |
Blank sheets for experiments,
undated
|
21 |
15 |
Crop,
6/25/1979
|
21 |
16 |
Brain development,
undated
|
21 |
17 |
Bonzo, film 21,
1985
|
21 |
18 |
Brain -- (Gelber) photos and negatives [photographs, negatives],
1967
|
21 |
19 |
Calibration of plastic standards,
1969-1975
|
21 |
20 |
Calibration of standards,
undated
|
21 |
21 |
Calibration standards using the 10 and "new low" standards"",
1986
|
21 |
22 |
Catheter -- calibration exp.,
1991-1992
|
21 |
23 |
Catheter smear collection,
undated
|
21 |
24 |
Caveness study materials [photographs],
undated
|
21 |
25 |
CCK -- vagotomized,
1980
|
21 |
26 |
Chico,
1980-1984
|
21 |
27 |
Chr. Li-1,
5/27/1980
|
136 |
12 |
Chromatogram Records,
1960
|
21 |
28 |
Chronic -- nitro i.p.,
1993
|
21 |
29-30 |
Chronic i.p. of L-NAME series vol. 1-2,
1993
|
21 |
31 |
Clinical trials of barbiturates in rats,
1972
|
21 |
32 |
Collaboration -- Bill Eckelman and Juntendo Univ.,
1999
|
21 |
33 |
Collaboration -- Dr. David M. Cohen,
2000-2003
|
21 |
34 |
Collaboration -- Dr. Rolf Gruetter -- Univ. of Minnesota,
1999-2001
|
21 |
35 |
Collaboration -- SuperGen,
1999-2000
|
21 |
36 |
Dee, film 8-35,
1978
|
21 |
37 |
Dee, film no. 7-35,
1979
|
21 |
38-39 |
Densitometric calibration curves,
1953-1955
|
21 |
40 |
Densitometry 1,
1953-1954
|
21 |
41 |
Densitometry 2,
1954
|
22 |
1 |
Deoxyglucose review,
1980-1981
|
22 |
2 |
Directories -- disk and tape,
1985
|
22 |
3 |
Discarded animals,
1972
|
22 |
4 |
Dreamless, film 17,
undated
|
22 |
5 |
Dreamless,
1980
|
22 |
6 |
ECF mixed culture (counting data),
1995
|
22 |
7 |
ECG, EOG and EMG (from Reivitch, et. Al.) [Slides],
1985
|
22 |
8 |
Effects of barbiturates on blood gases,
undated
|
22 |
9 |
Effects of epinephrine on blood glucose,
1958-1959
|
136 |
13 |
Effects of Thiopental Anesthesia on Local Cerebral Glucose Utilization in the Albino Rat,
undated
|
22 |
10 |
Equilibrium,
undated
|
22 |
11 |
ER-M, C-31'-236 uc.,
1973-1974
|
22 |
12 |
Exp. CC1,
1980
|
22 |
13 |
Exp. CC2,
1980
|
22 |
14 |
Exp. CC5,
1980
|
22 |
15 |
Exp. CR2,
1980
|
22 |
16 |
Exp. CR3,
1980
|
22 |
17 |
Exp. CR4,
1980
|
22 |
18 |
Exp. CR6,
1980
|
22 |
19 |
Exp. CR7,
1980
|
22 |
20 |
Experiment 6: raw data -- nucleotide separation by high voltage electrophoresis,
1970
|
22 |
21-22 |
Factor preparation and properties -- book 2,
1968-1974
|
22 |
23 |
Factor TLC scans,
1969
|
22 |
24 |
Failed experiment, Aug. 22,
1991
|
136 |
14 |
Fasting and Brain Metabolism,
1969-1973
|
136 |
15 |
G. Fitzgerald Experiments,
1971
|
22 |
25 |
G5 U4 with new 3 rate constants -- Ki*=.232, K2*=.240, K3*=0.61,
1985
|
22 |
26 |
GEE -- experiment work sheep,
1978-1979
|
22 |
27 |
GEE file no. 7-33,
1979-1980
|
22 |
28 |
Glucose deter.: Beckman vs. Gilford,
1975
|
22 |
29 |
Glucose deter.: with glass vs. Eppendorf pipets,
1975
|
22 |
30 |
Glucose determination (spectrophotometer),
undated
|
22 |
31 |
Glucose determination: glucose oxidase method,
undated
|
22 |
32 |
Glucose determination: miscellaneous,
1973-1975
|
22 |
33 |
GU-BMF (multi-film program),
undated
|
22 |
34 |
Guide to reading auto radiographs,
undated
|
22 |
35 |
Hemoglobinometry,
1979
|
22 |
36 |
HG misc.,
1980
|
22 |
37 |
High-std-1, 14c meth. Glucose,
1978
|
22 |
38 |
History: rat thyroidectomies,
1960-1966
|
22 |
39 |
Hydroxybuty rate assay,
1969
|
22 |
40 |
Hyperinsulinemia experiments,
1980
|
22 |
41 |
Info. on micropipettes and pumps,
1973
|
22 |
42 |
Insulin hypoglycemia (50 uci/animal),
undated
|
22 |
43 |
Internal standard,
1985
|
22 |
44 |
L.S. brain -- I,
1977
|
22 |
45 |
Laplace transform -- technical info.,
1975
|
22 |
46 |
Liquid scintillation media,
1974
|
22 |
47 |
List of research projects planned,
undated
|
22 |
48 |
Low standard I graph,
1977
|
22 |
49 |
LSD-DG series,
1975-1976
|
22 |
50 |
M. Shionohara -- summarized date,
1979
|
22 |
51 |
Manuscript -- Dr. Sokoloff [photographs],
undated
|
22 |
52 |
Marburg slides,
undated
|
22 |
53 |
Mean weighted average (GU) -- square exp. (GU was calculated with weighted average of tissue conce.),
1979
|
22 |
54 |
Mean weighted average of GU (GU was directly calculated by image processor),
undated
|
22 |
55 |
Metabolic maturation of the brain in relation to asphyxia neonatorum,
1963-1964
|
22 |
56 |
Milt,
6/14/1979
|
22 |
57 |
Milt, film no. 1-32,
1979-1982
|
22 |
58 |
Misc. papers,
1979-1980
|
22 |
59 |
Miscellaneous statistical analyses,
1960
|
22 |
60 |
Mixed and astroglial culture,
1995
|
22 |
61 |
Morphine summary,
undated
|
22 |
62 |
MTZ-1,
1/1/1975
|
22 |
63 |
MTZ-2,
1/2/1975
|
22 |
64 |
N.E.N. standard calibration,
1978-1979
|
23 |
1 |
NH3 -- 1-3, HF -- 1-2, GD -- 1-3, DLX, DX 1-4 Rats [X- Rays],
1977
|
23 |
2 |
N.O.S. assay,
1992-1993
|
23 |
3 |
Nitro i.p. -- enzyme assay,
1993
|
23 |
4 |
No synthase assay,
1992-1993
|
23 |
5 |
NOD,
3/18/1980
|
23 |
6 |
Nodoz [photographs],
4/8/1980
|
23 |
7 |
Nodoz, film 6,
1980
|
23 |
8 |
NOS activity after nitroarginine intracisternal infusion,
1993
|
23 |
9 |
Nose,
3/22/1979
|
23 |
10 |
OD vs. con. x time,
undated
|
23 |
11 |
Olf. Bulb,
undated
|
23 |
12 |
Original 3-rate constants,
1986
|
23 |
13 |
Parameters (pulse experiments ) 5 rate constants (K4*=0.0014),
1986
|
23 |
14 |
Parameters (pulse experiments) -- 5 rate constants (K4*=0.002),
1986
|
23 |
15 |
Parameters (square exp.) 5 rate constants,
1986
|
23 |
16 |
Parsley,
7/10/1980
|
136 |
16 |
Peroxidase Kinetics -- Model #1,
undated
|
136 |
17 |
Peroxidase Kinetics -- Model #2,
undated
|
136 |
18 |
Peroxidase Kinetics -- Model #3,
undated
|
23 |
17 |
Phosphate,
1979
|
23 |
18 |
Phosphate,
1978
|
23 |
19 |
Physiological conditions' summary -- pulse exp.,
undated
|
23 |
20 |
Plasma curves,
undated
|
23 |
21 |
Poly. fitting -- plastic standards,
1973
|
23 |
22 |
Posh,
8/6/1980
|
23 |
23 |
Pulse experiments parameters -- 5 rate constants (K4*=0.001),
1986
|
23 |
24 |
Pump schedule sheet,
undated
|
23 |
25 |
Puromycin -- originals negatives [negatives],
undated
|
23 |
26 |
Psychological vs. Physiological,
1961
|
23 |
27 |
Radiochemical specifications,
1967-1974
|
23 |
28 |
Rat DX-4,
1971
|
23 |
29 |
Rate constant experiments,
1970-1992
|
23 |
30 |
Red-outline drawings,
undated
|
23 |
31 |
REM4, awake cont. cat,
1976
|
23 |
32 |
REM5,
1976
|
23 |
33 |
Reproduce Iadecola's experiment,
1992
|
48 |
28 |
Research medicine [experiment proposal],
1992
|
23 |
34 |
Reza,
9/10/1979
|
23 |
35 |
Ribosomal protein -- orig. photos and neg. [photographs, negatives],
undated
|
23 |
36 |
Roche system -- originals and photographs [negatives],
undated
|
23 |
37 |
Rocky,
undated
|
23 |
38 |
Rocky,
10/26/1978
|
23 |
39 |
Rocky, film no. 1-32,
1979
|
23 |
40 |
Sakurada abstract -- effects of immobilization,
1977
|
23 |
41 |
Salicylates -- illus. and negatives [negatives],
undated
|
136 |
19 |
Separation of AMP, ADP, and ATP Using Electrophorisis,
1970-1971
|
23 |
42 |
Series AB: laplace transform, 2 DG. rats: BARB. ANES,
1975
|
23 |
43 |
Series AUD-111: auditory alterations,
1973
|
23 |
44 |
Series AUD-2: auditory alterations,
1974
|
23 |
45 |
Series AUD-3: auditory alterations,
1974
|
23 |
46 |
Series AUD-4: auditory alterations,
1974
|
23 |
47 |
Series CB: laplace transform, 2DG. rats: 5% CO2,
1975
|
23 |
48 |
Series NH: ammonium acetate -- 10 m. moles/kg i.p.,
1972
|
23 |
49 |
Series normal: normal values in rats,
1971
|
23 |
50 |
Series R-ER-1 to R-ER-7 -- trial at square wave rats -- conscious,
1974
|
23 |
51 |
Series WB: laplace transform, 2DG rats: conscious,
1975
|
23 |
52 |
Shaky [photograph],
12/20/1979
|
23 |
53 |
Short counts on Beckman L.S5801,
1985
|
23 |
54 |
Sierra,
1980-1984
|
23 |
55 |
Sleep -- spinal cord,
undated
|
24 |
1 |
Sleep (end Kennedy files),
1980
|
24 |
2 |
Sleep 1 (fang),
2/13/1980
|
24 |
3 |
Sleep study,
1981-1990
|
24 |
4 |
Snooz,
1/5/1980
|
24 |
5 |
Sparky -- myelinated [photographs],
1983
|
24 |
6 |
Spot -- sleeping,
2/12/1981
|
24 |
7 |
Standard calibration,
1979
|
24 |
8 |
Standard strip calibration from G. Dauth, neurosci., Univ. of Mich., Feb. 9,
1980
|
24 |
9 |
Standards,
1979-1983
|
24 |
10 |
Sugar,
1979
|
24 |
11 |
Sugar, film no. 1-28,
1979
|
24 |
12 |
Summarized data for computer analysis,
undated
|
24 |
13 |
Summary of parameters (pulse exp.) (square exp.),
undated
|
24 |
14 |
Summary of parameters (square exp),
undated
|
24 |
15 |
Summary sheets,
1968-1974
|
24 |
16-20 |
Summary tables and graphs,
undated
|
24 |
21 |
T3 Be Vwa time course data for Dr. Greenhouse,
undated
|
24 |
22 |
Tent rat training record,
1993
|
24 |
23 |
TSC-1, Nov. 10,
1975
|
24 |
24 |
TSC-2, Dec. 1,
1975
|
24 |
25 |
TSC-3, Dec. 2,
1975
|
24 |
26 |
TSC-4, Dec. 4,
1975
|
136 |
20 |
University of Pennsylvania [Research Notes],
1950-1953
|
136 |
21 |
[Unidentified Research Notes],
[circa 1950s]
|
24 |
27 |
Values of rate constants in the normal conscious albino rat,
undated
|
24 |
28 |
Visual alteration: enucleation,
1973
|
24 |
29 |
Weighted average concentration -- (pulse experiments) Dr. Shinohara's data,
1986
|
24 |
30 |
Whole blood samples,
undated
|
24 |
31 |
Windy,
1978
|
24 |
32 |
Windy [photograph],
1978-1979
|
24 |
33 |
Windy, film no. 7-33,
1978
|
24 |
34 |
Winx,
1985
|
24 |
35 |
Winx (sleep control),
1980
|
24 |
36 |
Winx, film 16,
1987
|
|